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ABSTRACT
Enzymes, as highly efficient biocatalysts, have been researched extensively in both
academia and industry because of their distinct advantages including high substrate
specificity, high regio- and stereoselectivity, environmentally benign process, etc. Though
enzyme catalysis has been scaled up for commercial processes in the pharmaceutical, food
and beverage and detergent industries, technical barriers associated with enzyme
implementation persist, i.e., low catalytic efficiency at non-natural environment,
exhausting product separations, high cost of certain enzymes, etc. Moreover, currently
most industrial enzymes are used in single-step reactions; however, multistep and
multienzyme catalysis with optimal efficiency could greatly expand its potential for
synthetic applications to achieve complex chemical transformations. In this dissertation,
we use a polymer protein co-assembly strategy to construct core-shell nanoparticles to
study multistep and multienzyme involved catalysis. An electrokinetics (EK) based
microfluidic method has been explored to improve the polymer-protein(s) co-assembly and
fabricate homogenous polymer-enzyme hybrid nanoparticles. A group of small molecules
have been characterized as efficient P450 OleTSA enzyme activators providing novel
strategies to enhance enzyme activity in situ. Finally, a surfactant assisted enzyme involved
microemulsion formation via interfacial assembly has been studied.
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INTRODUCTION
Multienzyme based complex chemical transformations are common in biological
processes ranging from protein synthesis to cellular metabolism. In nature, microorganisms
have evolved features to maximize the catalytic efficiency of multienzyme based
transformations by spatial organization, co-localization and microcompartmentation,
through which proximity of multiple components of enzyme complex, mass transportation
in the multistep catalysis can be sufficiently improved. Inspired by those biological
systems, different strategies have been explored to improve multienzyme based catalysis
including DNA scaffolds, protein scaffolds, polymeric particles assemblies, metal-organic
frameworks, hydrogel encapsulation and cross-liked enzyme aggregates. While
structurally and mechanistically diverse, the ultimate goal of these multiple enzyme
assemblies is to accelerate reaction velocity and increase reaction efficiency. In this
dissertation, protein(s) co-assembly strategies including protein-polymer co-assembly,
protein-surfactant interfacial assembly have been explored to construct protein complexes
in order to increase the enzymes’ activity.
In Chapter 1, poly(4-vinylpyridine) polymer-arylamine N-oxygenase core shell
nanoparticles (P4VP-CmlI) have been generated through co-assembly and studied to
explore their potential use in a bio-catalytic platform. P4VP-CmlI shows excellent activity
on two arylamine substrates, p-aminophenol (pAP) and p-aminobenzoic acid (pABA),
using turnover methods that employed a surrogate redox system or a peroxide shunt.
Products at different oxygenation stages can be generated with different substrates. In
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comparison to the free enzyme, P4VP-CmlI hybrids have a significantly enhanced catalytic
efficiency when using pyridine nucleotide (NADH) and appropriately poised redox
mediators. The enhanced catalytic efficiency of the P4VP-CmlI assemblies is attributed to
a more efficient electron delivery.
In Chapter 2, we report an artificial enzyme cascade composed of glucose oxidase
(GOx) and OleTSA from Staphylococcus aureus for efficient terminal alkene production.
By adjusting the ratio of GOx to OleTSA, the GOx-based tandem catalysis shows
significantly improved product yield compared to the H2O2 injection method. The coassembly of the GOx/OleTSA enzymes with a polymer, forming polymer-multienzymes
nanoparticles, displays improved activity compared to the free enzyme. This two-fold
strategy provides a simple and efficient system to transform a naturally abundant feedstock
to industrially important chemicals. We attribute the enhanced effect of the co-assemblies
origins from presence of large amount of OleTSA as H2O2 target on the nanoparticles
surface as well as the closed proximity of the two enzymes after co-assembly.
In Chapter 3, we explore an electrokinetics (EK) based microfluidic reactor with
fast mixing to assemble functional proteins with polymers in an ethanol/water co-solvent
system. The resultant NPs show significantly improved size distribution by comparison
with the ones prepared using conventional bulk method, while the NPs size can be tuned
by adjusting the mass ratio of polymer to protein. The functionalities of the assembled
proteins are sustained upon the EK based microfluidic mixing, indicating the application
potential of our method in the controlled assembly of different functional proteins. This
work sheds light on the application of this EK-based microfluidic method for polymer
enzyme(s) co-assembly.
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In Chapter 4, we report the use of a class of small molecules to enhance OleTSA
enzymatic activity in situ. Up to 6-fold enhanced activity has been obtained with small
molecules synthesized in house. The small molecules and enzyme substrates co-locate at
the enzyme active site simultaneously. We propose the origins of the enhancement are from
the enzyme oxidation step and an H2O2 toxicity inhibiting effect.
In Chapter 5, we use cytochrome P450 OleTSA as a model to study the interaction
of surfactant and enzyme and its utilization for interfacial assembly. Both negative and
positive surfactants can interact with OleTSA and facilitate emulsion formation via
interfacial assembly. In particular, sodium dodecyl sulfate (SDS), a negative surfactant,
has been identified as the optimal one to interact with OleTSA, which can form stable
emulsions via the interfacial assembly. Biphasic enzymatic reactions have been conducted
with fatty acids as substrates dissolved in hexane while the enzymes (GOx/OleTSA) located
at the interface of organic/aqueous layer. With this system, the terminal alkene products
can be enriched in organic layer during the catalysis, and the overall turnover rate is
comparable to that in conversional single-phase reactions.
Overall, we demonstrate that protein(s) co-assembly could be a viable approach to
manipulate and improve the multistep and multienzyme based catalysis via different
mechanisms. In Chapter 6, we provide some perspectives on future works to further
understand the co-assembly process as well as how the process effects on enzyme catalysis,
which will be beneficial to expand such strategies in enzyme engineering.
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CHAPTER 1
ENHANCED ARYLAMINE N-OXYGENASE ACTIVITY OF POLYMER-ENZYME
ASSEMBLIES BY FACILITATING ELECTRON-TRANSFERRING EFFICIENCY

Portions of this chapter appear in the following manuscript:
L. Zhang, Y. Xu, T.M. Makris, Q. Wang, Biomacromolecules. 19 (2018) 918–925.
Reprinted here with permission. Copyright (2018) American Chemical Society.
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1.1 INTRODUCTION
Nitro- and nitrosoaromatic compounds1,2 are two important classes of chemicals
which have been widely used as pharmaceuticals, pesticides, dyes, explosives and building
blocks for synthesis and materials development.3–7 Although various synthetic methods
have been developed over the decades,1,2,8 safety concerns, a lack of regioselectivity, and
the resulting instability of the nitroso-compounds under the harsh preparatory conditions
required often limit their preparation. As with other transformations, bio-catalytic
platforms that can be carried out under mild reaction conditions have attracted significant
attention for synthetic applications for these compounds.9–11
Arylamine N-oxygenases catalyze the six-electron oxidation of aryl-amines to arylnitro compounds via hydroxylamine and nitroso intermediates,12–16 providing a novel tool
for stepwise Ar-NO and Ar-NO2 synthesis. Among these newly-characterized enzymes,
CmlI is a representative arylamine N-oxygenase that utilizes a dinuclear-iron cofactor to
catalyze the formation of the bioactive nitro-group of the antibiotic chloramphenicol
(CAM) via oxidation of the arylamine precursor (NH2-CAM).16 The mechanism and
structure of CmlI reveal that the enzyme catalyzes N-oxygenation through successive
reactions with an atypical (relative to other dinuclear oxygenases) and highly stable
peroxo-diferric intermediate that is generated from reaction of the reduced diferrous protein
with dioxygen.17–19 Interestingly, in addition to the final nitro-containing compound,
nitroso- products can also accumulate in the enzymatic reaction with native substrate, NH2CAM.17 Thus, CmlI may be a promising biocatalyst for leveraging Ar-NO2 and/or Ar-NO
synthesis if the oxygenation process can be controlled.

5

The use of N-oxygenases such as CmlI for synthetic applications is restricted by
low catalytic efficiency. A native redox partner system that generates the diferrous form
that subsequently reacts with O2 has yet to be identified. It has been reported that the
activity of CmlI, and AurF, a closely related ortholog involved in aureothin biosynthesis,
can be reconstituted using a surrogate redox system comprised of reduced pyridine
nucleotide (NADH) and the redox-mediator phenazine methosulfate (PMS) (Scheme
1.1).16,20 However, the uncoupled consumption of reducing equivalents likely resulting in
the generation of damaging reactive oxygen species that may limit activity. An alternative
method is to use H2O2 to bypass the need for reducing equivalents altogether and generate
the reactive peroxo species directly (Scheme 1.1). This approach has been used to initiate
turnover in various dinuclear-iron enzymes (e.g. AurF, soluble methane monoxygenase
(sMMO) and toluene 4-monooxygenase (T4Mo))21–24 and variable levels of enzyme
activity have been reported. For example, recent studies that have explored the shunt
pathway in CmlI have shown that the addition of H2O2 to the diferric enzyme does not
readily form the reactive peroxo-adduct that reacts with substrates.18

Scheme 1.1 Illustration of the reconstitution of CmlI activity using NADH/PMS and
dioxygen or via a peroxide shunt method. to generate a diferric-peroxide intermediate that
reacts with arylamine substrates.
6

Polymer/enzyme hybrids have served as an alternative method for enzyme
engineering. Upon polymer conjugation, many enzymes can exhibit improved stability, pH
or temperature tolerance and catalytic efficiency with different mechanisms imparted by
specific polymer structures.25–30 The construction and characterization of pyridine-grafted
polymer-protein core shell nanoparticles (PPCS-NPs) has been systematically discussed in
previous studies by our laboratory.31–36 The synthesis of PPCS-NPs is primarily
entropically-driven, while the resultant nanoparticles are stabilized by synergistic
interactions between polymers and proteins. The finely-balanced microenvironment can
help to preserve enzyme conformation and function.36 With a robust one-step co-assembly
protocol, the proteins bound on the surface of the PPCS-NPs was greater than 90% in
comparison to the initial amount of the protein used. The PPCS-NPs were found typically
stable in solution for about 1−2 weeks at room temperature and 4 weeks at 4 °C. During
the process, no protein leaching has been observed.36 A broad range of functional proteins
and protein cages have been co-assembled with specific polymers to form PPCS-NPs.36–38
Moreover, the pyridine-containing polymers can exhibit a high electron affinity and
favorable electron-donation properties from the pyridine unit.39–41 Collectively, these
studies indicate that P4VP polymer assembly may be leveraged with CmlI to improve its
performance as a biocatalyst. In the present study, we have generated P4VP-CmlI coreshell nanoparticles through a co-assembly process and tested their catalytic activity with
the arylamine substrates pAP and pABA. Interestingly, we observed that different
intermediate products accumulate with these two substrates. We found that P4VP-CmlI
showed significantly higher activity on both substrates than the free enzyme that is
attributed to a more efficient electron delivery process due to proximity of enzymes and
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cofactors. This step is rate-limiting in many classes of oxidoreductases42,43 and the
identification of native redox-delivery systems can be a major bottleneck if the genes that
encode them are located outside of the immediate genetic locus. As a result, the P4VPenzyme assembly method may be generally applicable to leverage oxidoreductase catalysis
in a variety of synthetic platforms.
1.2 EXPERIMENTAL SECTION
1.2.1 MATERIALS
P4VP (Mw 60000), p-aminophenol (pAP, >99.0%), flavin mononucleotide (FMN)
and riboflavin were purchased from Sigma-Aldrich. Phenazine methosulfate (PMS,
>98.0%), p-aminobenzoate (pABA, >99.0%) were purchased from TCI America. NADH
sodium salt was purchased from EMD Millipore. Unless otherwise noted, all chemicals
and solvents used were of analytical grade and were used as received from commercial
sources. Water (18.2 MΩ) was obtained from Milli-Q system (Millipore). Unless otherwise
noted, all buffers are 50 mM 3-(N-morpholino) propane sulfonic acid (MOPS), pH 7.4.
1.2.2 HETEROLOGOUS EXPRESSION AND PURIFICATION OF CMLI
The Streptomyces venezuelae CmlI gene, cloned into the pVP91A expression
vector and characterized in previous studies,19 was used for protein expression. This vector
contains an eight-histidine tag at the N-terminus to facilitate purification. Expression of
CmlI was performed in E. coli BL21 (DE3) in LB medium in the presence of 100 µg/mL
ampicillin. Cells were grown to an OD ~ 1.0 and induced with 150 µM IPTG and 50 µM
FeCl3 at which point the temperature was lowered to 20 °C, and grown for an additional
15 h. Cells were harvested by centrifugation for purification or stored at -80 °C for further
use. The protein was purified using nickel-nitriloacetic acid (Ni-NTA) affinity
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chromatography as described previously 19 and was subsequently dialyzed against 50 mM
MOPS pH 7.4 buffer and stored at -80 °C until further use. Enzyme purity was assessed by
SDS-PAGE and the iron-to-enzyme ratio was verified by the ferrozine assay (Figure S1).44
1.2.3 SYNTHESIS OF P4VP-CMLI ASSEMBLIES
A solution of P4VP in ethanol (7.5 mg·mL-1, 0.1 mL) was slowly added to a
solution containing CmlI in 50 mM MOPS pH 7.4 (1.2 mg·mL-1, 0.9 mL) with stirring.
After addition, the mixture was stirred for an additional 30 minutes. To study the influence
of FMN reduction by NADH, the P4VP-CmlI assemblies were prepared with a similar
procedure but with diluted P4VP (0.75 mg·mL-1, 0.1 mL) and CmlI enzyme (0.12 mg·mL1

, 0.9 mL) in 50 mM MOPS pH 7.4. All the assembled samples were freshly prepared in

the characterization and activity test.
1.2.4 CHARACTERIZATION OF P4VP-CMLI ASSEMBLIES
The P4VP-CmlI sample (20 µL) was centrifuged to collect the nanoparticles and
resuspended with the same volume of water, dropped onto a stub and dried in the hood,
then coated with a thin layer of gold film using a Denton Vacuum Desk II. The sputtered
samples were fixed onto the sample holder and placed in the vacuum chamber of the
microscope under low vacuum (1025 Torr) for imaging by the in-lens detector of Zeiss
Ultraplus Thermal Field Emission Scanning Electron Microscope (FESEM). For TEM
analysis, the sample was diluted 100 times by water, 20 μL diluted sample was dropped
onto 300-mesh carbon-coated copper grids and dried. The grids were then stained with 20
μL of uranyl acetate (2% w/v) for 5 minutes and observed with a Hitachi H-8000 electron
microscope. The size distribution of P4VP-CmlI assemblies were measured with dynamic
light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). The mean value for the
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size based on the intensity, and the polydispersity index (PDI), a dimensionless width
parameter based on the cumulant analysis, were detected.
1.2.5 ACTIVITY ASSAY OF P4VP-CMLI ASSEMBLIES AND FREE CMLI
The activity assay of both P4VP-CmlI and free CmlI were performed in a reaction
volume of 100 μL. The final reaction mixture contained CmlI (20 μM), the substrate pAP
or pABA (1 mM), PMS or FMN or riboflavin (12.5 - 125 μM), NADH (1 - 10 mM), and
7% ethanol in MOPS buffer. Reactions were performed at room temperature (23 – 25°C)
and were initiated by the addition of the substrate to the reaction mixture. The specific
activity was calculated during the first 10 minutes. The PMS, FMN and riboflavin reagent
were freshly prepared and kept dark until use. NADH and PMS or FMN or riboflavin were
added immediately before each reaction to minimize any possible side reactions in the
presence of oxygen.45 P4VP-CmlI and CmlI reactions were prepared and tested side-byside for an accurate comparison of activity. Reactions with pAP were measured by
monitoring pNOP product formation at an absorbance of 405 nm with a Molecular Device
SPECTRAMax plus 384 with a microplate reader using 0.33 cm path length. The activity
assay with pABA was performed with the same procedure, the products were quantified
by HPLC as described below. The assays were performed in at least triplicates and the
averages were reported.
1.2.6 PEROXIDE-SHUNT ASSAY
Peroxide-shunt experiments were performed by the addition of H2O2 to the solution
containing enzyme and substrate. Final reactions contained CmlI (20 μM), pAP or pABA
(1 mM), 1.5% H2O2 (v/v) and 7% ethanol in MOPS buffer (50 mM, pH 7.4). The activity
was quantified by HPLC as described below. To compare the stability and activity of the
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assembled enzyme complexes with that of the free enzyme, a pre-treatment time course
study was done with pre-incubation of P4VP-CmlI and free enzymes with 1.5% H2O2 (v/v)
for 0 h, 1 h, 2 h, 5 h, then the activity test was followed.
1.2.7 HPLC AND MS ANALYSIS
Reactions with pAP were quenched by trifluoroacetic acid (final concentration
2.5% v/v). Reactions with pABA were quenched using acetic acid (final concentration 1%
v/v). After quenching, samples were centrifuged at 15,000 g at 4 °C for 15 minutes and
the supernatant was collected. Due to the sensitivity of aryl-nitroso compounds towards
NADH,46 both P4VP-CmlI and free CmlI catalyzed reactions were analyzed by HPLC
immediately after quenching and centrifugation. The products were identified and
quantified using an Agilent 1100 series HPLC equipped with a ZORBAX SB-C18 column.
HPLC parameters were as follows: 25°C; solvent A, 1% acetic acid in water; solvent B,
methanol; gradient, 10% B for 2 min; then, from 10% B to 100% B over 18 min; flow rate,
0.5 ml/min. Detection of the products resulting from pAP metabolism was by UV
absorbance at 305 nm. Those from pABA reactions were monitored at 268 nm.
Quantification was done based on the peak area of the corresponding compounds. LC-MS
with electrospray ionization was carried out in Mass Spectrometry Center, USC to identify
the pHABA.
1.2.8 FMN REDUCTION RATE TEST
MOPS 50 mM pH 7.4 buffer was degassed for 30 minutes before used for P4VPCmlI assembly, solutions of FMN (500 μM), NADH (50 mM) and P4VP- and free CmlI
enzyme were degassed separately for 10 minutes and diluted with MOPS buffer before
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each test. UV−Vis absorption studies were performed using an Agilent 8453 UV−Vis
spectrometer (1 mm path length) with exposure of air.
1.3 RESULT AND DISCUSSION
1.3.1 P4VP-CMLI SYNTHESIS AND CHARACTERIZATION
CmlI enzyme was purified by using nickel-nitriloacetic acid (Ni-NTA) affinity
chromatography. The purity was identified by SDS-PAGE as shown in Figure 1.1. A
robust one-step protocol for PPCS-NPs generation through co-assembly was described in
detail in previous studies.36 In our work, P4VP polymer was dissolved in ethanol then
added into CmlI enzyme solution drop wisely with vigorous stirring. After addition, the
mixture was stirred for an additional 30 minutes for equilibration (Figure 1.2a). Because
of the high loading capacity of the PPCS-NPs,36 the equilibrated P4VP-CmlI sample was
used in the following morphology test and enzymatic assay without a further purification.
Based on the FESEM results (Figure 1.2b), P4VP-CmlI core shell nanoparticles were
successfully generated. Dynamic light scattering (DLS) analysis revealed the average
diameter of P4VP-CmlI nanoparticles was around 200 nm and the polydispersity index
(PDI) was 0.107, showing considerable homogeneous nanoparticles formed (Figure 1.2c).
This was consistent with our previous research results.32,36

Figure 1.1 SDS-PAGE of purified CmlI enzyme
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Figure 1.2 (a) Schematic representation of the preparation of P4VP-CmlI in MOPS buffer
at pH 7.4. (b) FESEM image of P4VP-CmlI nanoparticles. Inset shows an enlarged image
of a single particle. (c) Size distribution of P4VP-CmlI nanoparticles based on DLS
measurement.
1.3.2 CATALYTIC ACTIVITY OF P4VP-CMLI
Aside from reactions with the native NH2-CAM substrate, there is only limited data
that defines the substrate scope for CmlI reactions.16 From transient kinetics measurements,
it is known that the peroxo-CmlI adduct exhibits enhanced rates of decay in the presence
of arylamine compounds with different para substituents including pAP, pABA and LpAPA (L-para-aminophenylalanine).19 However, the products for these reactions have not
been identified. In this study, pAP and pABA were chosen as model substrates for
characterizing P4VP-CmlI activity. Based on reported catalytic mechanism of CmlI, the
nitro substituted compounds (pNP and pNBA) should be produced as the final six-electron
oxidized products, while the analogous hydroxylamino- (pHAP and pHABA) and nitrosocompounds (pNOP and pNOBA) may be observed as intermediate products (Scheme
1.2).17 It was reported that an arylamine N-oxygenase isolated from Pseudomonas syringae
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pv. Phaseolicola (PsAAO), a closely-related ortholog of AurF and CmlI, could tolerate and
even showed higher activity in the presence of methanol.21 We found that CmlI had similar
characteristics, i.e. the presence of 7% ethanol increased the enzyme activity by
approximately 50%. To get consistent results, the P4VP-CmlI NPs were tested in the 7%
ethanol/MOPS co-solvent without further purification after the co-assembly.

Scheme 1.2 Schematic representation of CmlI catalyzed reaction with pAP and pABA as
substrate *The shaded products were observed with NADH/PMS method.
The activity of P4VP-CmlI was reconstituted using a redox system composed of
NADH and the mediator phenazine methosulfate (PMS). The activity was alternatively
assessed with a peroxide-shunt method using 1.5% H2O2 (v/v). The pAP and pABA
substrates tested here have opposing electrophilicities at the para substitution (Scheme
1.2). Very interestingly, while both pAP and pABA could serve as substrates for CmlI, we
observed that for pAP, the intermediate product pNOP, rather than the fully oxidized pNP,
was accumulated for both the P4VP-CmlI and free CmlI catalyzed reactions using either
method (Figure 1.3a, Figure 1.4). In contrast, when pABA was used as a substrate, the
intermediate product pHABA was accumulated with the NADH/PMS method (Figure
1.3d-f) and pNBA was accumulated with the peroxide-shunt method (Figure 1.5). For
comparison, the ortholog AurF was reported to have activity with pABA, but no activity
was observed with pAP.22 AurF also exhibits product distributions that depend on the
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turnover methods utilized which was attributed to different reaction steps being ratelimiting.22
The mechanisms why intermediate products can escape from the enzyme active
center have not been well understood so far. In this study, smaller size of the two unnatural
substrates by comparing their native counterpart could partially explain why they can easily
release from the enzyme active center without fully oxidation. The proposed mechanism
for CmlI catalysis invokes an amphiphilic nature of the peroxo-CmlI oxidant, which could
perform electrophilic (for amine or hydroxylamino) or nucleophilic oxidations (for nitroso)
of substrates respectively.17 Each of these would be expected to be highly sensitive to the
nature of the para substituent. As a result, product distributions and activity would be
expected to alter as we observed here.

15

16
Figure 1.3 Enzymatic activity analysis of P4VP-CmlI assemblies: 20 μM enzyme, 1 mM pAP or 1 mM pABA, 2 mM NADH and 25
μM PMS in MOPS buffer (50 mM, pH 7.4). (a) HPLC analysis of the enzymatic oxidation products of pAP catalyzed with P4VP-CmlI.
(b-c) Comparison of the activity of P4VP-CmlI and free CmlI using pAP based chromogenic assay, the signal at the first read was
subtracted as background. (d-f) HPLC analysis of the oxidation products using pABA as the substrate with free CmlI (d) and P4VPCmlI as the catalyst (e) and the pure pABA (f). (g-h) Activity comparison based on the consumption of starting material pABA (g) and
the production of the intermediate pHABA (h). Error bars represent the standard deviation of the mean of triplicate sample.

With P4VP assembly, all these enzyme functions were maintained. It is noteworthy
that the activity of enzyme assembly with NADH/PMS method showed around 1.6 to 2.3
times increase compared to the activity carried out via the peroxide shunt method. In
addition, the highly sensitive of P4VP-CmlI to NADH/PMS concentration, which will be
discussed as below, makes the enzyme assemblies potentially used for synthetic
applications. The enzyme activity results showed near-ideal enzyme activity behavior
especially in the initial region. For longer reaction time, it showed a biphasic behavior.
Although we still do not know the precise origins for such phenomenon, a similar
observation has been also reported by another group.16 To the best of our knowledge, this
study is the first report that, with different substrates, products at different oxygenation
stages can be selectively enriched by CmlI. Continued investigation using a wider
substrate-scope may reveal new opportunities for synthetic applications.
1.2.3 ACTIVITY COMPARISON OF P4VP-CMLI AND FREE CMLI
In order to compare the catalytic efficiency of P4VP-CmlI and free CmlI, the free
enzyme was tested under the same conditions used in the preparation of P4VP-CmlI. For
pAP with NADH/PMS method, reactions were monitored by absorbance spectroscopy (
= 405 nm) to monitor the production of pNOP (Figure 1.3b). The specific activity of
P4VP-CmlI was as much as 5 times higher than that of the free enzyme (Figure 1.3c). For
pABA, the activity of P4VP-CmlI was around ~ 1.6 times of that of free enzyme, as
calculated by either the consumption of substrate (Figure 1.3g) or by pHABA production
(Figure 1.3h) through the HPLC quantification.
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Figure 1.4 HPLC result of P4VP-CmlI assembly and free CmlI enzyme reaction with pAP with different assays (a-b) the reactions with
2 mM NADH, 125 μM PMS (c-d) the reactions with 1.5% H2O2 (e) P4VP-CmlI catalyzed reaction with NADH/FMN (f) P4VP-CmlI
catalyzed reaction with NADH/riboflavin. All the reactions were done in pH 7.4, 50 mM MOPS buffer at 30 minutes. (g) HPLC traces
of pNOP and pNP standards.
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Figure 1.5 P4VP-CmlI and free CmlI activity test with H2O2 method using pABA as substrate. (a-b) Comparison based on the pABA
consumption (a) and pNBA production (b). HPLC results of the reactions at 0.5 hours (c-e), 1.5 hours (f-h), 5 hours (i-k), 23 hours (ln) were reported.

The reaction of PMS and NADH has been reported to produce hydrogen peroxide,47
which at high enough levels may contribute to enzyme activity. To test this possibility, 1
μM catalase was included in the CmlI/pAP/NADH/PMS reaction. Only minor differences
in activity were observed upon the addition of the H2O2 scavenger (Figure 1.6a). This
suggests that CmlI catalysis from pyridine nucleotide likely proceeds by a reductive
mechanism where the peroxo-adduct is formed from electron transfer and subsequent O2
binding. To further explore why P4VP-CmlI exhibits enhanced turnover rate, the
enzymatic activity assay with pAP was performed at different NADH/PMS concentrations.
As expected, when both NADH and PMS were at higher concentrations (NADH 10 mM,
PMS 125 μM), both P4VP-CmlI and free CmlI showed higher activity due to sufficient
and fast electron delivery (Figure 1.6b). However, when the concentration of PMS was
increased to 125 μM but the NADH kept at 2 mM, the difference between the activities of
P4VP-CmlI and free CmlI became negligible due to the dramatically increased turnover of
the free enzyme (Figure 1.6b). This implies that the electron transferring process mediated
by PMS could be facilitated in the P4VP-CmlI reaction and this difference was masked by
increasing PMS concentration. It is noteworthy that product formation time course by CmlI
showed a lag-phase, possibly due to a side reaction between the nitroso intermediate and
NADH/PMS.46 Interestingly, this effect can be rescued in the P4VP-CmlI catalyzed
reaction (Figure 1.6b). This phenomenon could be attributed to potential interactions
between P4VP polymer scaffold and PMS, which is still under investigation.
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Figure 1.6 Enzymatic activity comparison of P4VP-CmlI and free CmlI with adding
catalase (a), with different PMS/NADH concentration (b), with NADH/FMN or
NADH/riboflavin system (c) and by peroxo-shunt method (d). For (a), 25 μM CmlI was
used in CmlI/NADH/PMS reaction, 25 μM CmlI and 1 μM catalase were used in
CmlI/NADH/PMS + catalase reaction. All the reactions were done with 2.5 mM NADH,
125 μM PMS, 1 mM pAP, 7% ethanol in MOPS buffer (50 mM, pH 7.4). For (c), 1 mM
NADH and 12.5 μM FMN or Riboflavin were used and the reaction was stopped at 60
minutes. For (d), 1.5% H2O2 (v/v) was used. From (b) to (d), the reactions were done with
20 μM enzyme, 1 mM pAP in MOPS buffer (50 mM, pH 7.4). Error bars represent the
standard deviation of the mean of triplicate tests.
Flavin mononucleotide (FMN) and riboflavin, common biological redox partners
used in a plethora of redox processes,48–50 were utilized as alternative reducing systems. As
shown in Figure 1.6c and consistent with the results from PMS, the activity of P4VP-CmlI
was higher (~ 30%) than the free enzyme with pAP substrate. However, the overall
efficiency was much lower than that of the NADH/PMS couple. Based on above data, we
hypothesized that the origin of the enhanced activity for P4VP-CmlI may derive from an
enhanced rate of electron delivery to form the diferrous cluster. To test this, the activity of
P4VP-CmlI and free CmlI was compared to a peroxide-shunt method in which the
reduction process was bypassed (Scheme 1). The result showed no significant activity
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difference between the P4VP-CmlI and free CmlI (Figure 1.6d). This indicated that the
enhanced activity of P4VP-CmlI using NADH was most likely from the enzyme reduction
step. To further identify the effect of H2O2 on the stability and activity of peroxo CmlI
intermediate in assembled and free conditions, the H2O2 pre-treatment study was
performed. In this test, both P4VP-CmlI and free CmlI were pretreated with 1.5 % H2O2
(v/v) and aged for different times prior to the addition of pAP. There was no significant
difference between P4VP-CmlI and CmlI indicating uncompromised stability and activity
of both samples (Figure 1.7).
1.3.4 FMN REDUCTION TEST IN P4VP-CMLI AND FREE CMLI SOLUTIONS
In order to further demonstrate that an enhancement in electron transfer conferred
higher activity in P4VP-CmlI, the transfer of electrons from NADH to FMN was tested by
optical spectroscopy. NADH, in its reduced form, absorbs at 340 nm and oxidized FMN at
440 nm. The reduction of FMN by NADH can thus be monitored by the loss of absorbance
at both wavelengths. The absorbance spectrum of P4VP-CmlI has background
contributions due to scattering of the nanoparticles (Figure 1.8). As one could expect,
oxidation of NADH occurs for both P4VP-CmlI and free CmlI due to the reaction of FMN
and NADH. However, P4VP-CmlI shows a much faster rate of NADH oxidation (Figure
1.9a), and as a consequence, significantly faster FMN reduction (Figure 1.9b-c)
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Figure 1.7 P4VP-CmlI and free CmlI activity test with different time of H2O2 pretreatment using pAP as substrate. (a-f) HPLC result
of corresponding reactions. (g) Activity comparison based on the pNOP production.

Figure 1.8. UV-Vis spectra of P4VP-CmlI solution and free CmlI solution at MOPS
buffer.

Figure 1.9. Reduction test of FMN by NADH in P4VP-CmlI and free CmlI solution. (a)
UV-Vis spectra of P4VP-CmlI solution (red) and free CmlI solution (black) at MOPS
buffer. (b) Time resolved FMN (30 µM) in presence of NADH signal (200 µM) in P4VPCmlI and free CmlI solution. (c) Time courses for the reduction of FMN (50 µM) by NADH
(5 mM) in P4VP-CmlI solution, free CmlI solution and MOPS buffer.
1.4 CONCLUSIONS
In this study, we have generated P4VP-CmlI core-shell nanoparticles via a facile
self-assembly process and explored its activity with two substrates pAP and pABA using
both oxidative and reductive turnover methods. Nitroso- and nitro- products could be
selectively produced with different substrates using different co-substrates to initiate the
reaction. We found that the P4VP assembly could significantly increase CmlI activity using
NADH as an electron source and appropriate electron mediators. As redox partners are
required for the efficient turnover of CmlI but have yet to be identified, reconstitution of
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the enzyme activity in vitro is a major challenge. The P4VP polymer assembly system
improves the reduction of the enzyme in the absence of protein-based redox partners, and
as a result, showed significant enhanced activity. P4VP is an inexpensive polymer available
at an industrial scale, and the polymer-enzyme co-assembly process is both robust and
facile. The P4VP-CmlI nanoparticles reported here could thus be easily used for synthetic
applications.
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CHAPTER 2
ENHANCED P450 OLETSA CATALYSIS PROMOTED BY COUPLING WITH
GLUCOSE OXIDASE AND CO-ASSEMBLY
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2.1 INTRODUCTION
Driven by shortage of fossil fuel reserves and increasing environmental concerns,
tremendous efforts have been undertaken to transform bio-based feedstock into
chemicals1,2 and fuels3–5. Among them, the conversion of bioavailable carboxylic acids
(e.g., fatty acids) into terminal alkenes attracts attention because of their applications as
next-generation fuels and key chemicals for the production of lubricants, surfactants,
detergents, plastics, etc.6–9 To achieve this goal, different methodologies have been
developed such as esterification, amidation 10 and chemical reductions11,12. Despite of the
success of these methods, the requirement of precious transition metal catalysts and the
harsh reaction conditions often raise environmental concerns. Therefore, enzyme-catalyzed
oxidative decarboxylation reactions that can directly produce terminal alkenes in mild
conditions provide viable alternative approaches.13–15
A promising enzymatic alternative, cytochrome P450 OleT from Jeotgalicoccus sp.
8456, was first identified as an efficient olefin producer by Rude and coworkers.16 OleT
catalyzes the oxidative decarboxylation of fatty acids to yield primarily terminal alkenes
and CO2 or minor α- and β-hydroxylated fatty acids side-products.16–18 Whereas the
majority of P450s activate atmospheric O2 using pyridine dinucleotide as a reducing source
and an auxiliary redox chain,19 OleT utilizes H2O2 as the only electron- and oxygen-source
throughout the catalytic cycle (Figure 2.1a).20 Unlike NAD(P)H, H2O2 is inexpensive and
easily scalable, and previous efforts have sought to rewire P450s for efficient peroxide
utilization.21 However, the low turnover rate and low stability in the presence of excess
H2O2 limit the practical use of OleT. Very recently, a functional ortholog from
Staphylococcus aureus, OleTSA,22,23 was characterized by the Makris group and others that
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possesses improved features including enhanced solubility and high stability. These
features enable this ortholog to be a promising candidate for production applications.

Figure 2.1 a) Scheme of the cytochrome P450 OleT enzyme catalytic cycle. OleT is in a
low-spin ferric resting state with its heme iron axially coordinated by cysteine thiolate and
a H2O molecule, which shows a maximum Soret band at 418 nm.24 Substrate binding
displaces the axial water and converts the heme iron from low-spin to a high-spin state with
a maximum Soret band at 394 nm.24 Subsequent H2O2 activation forms Compound I,18
which abstracts a hydrogen atom from the Cβ position (HAT step), resulting in formation
of a substrate radical and the Fe4+-hydroxo species (compound II).25 Further substrate
oxidation, and recruitment of a proton results in the elimination of CO2 (PCET step) and
terminal alkene formation. b) Schematic representation of GOx/OleTSA cascade using
glucose as a substrate to produce H2O2 in situ.
One major issue of the H2O2-dependent biocatalysts towards their industrial
applications is enzyme inactivation.26 High concentrations of peroxide will generally
oxidize key amino acids (e.g. methionine, tryptophan) in the vicinity of enzyme active
site27–29 or directly destroy the porphyrin cofactor, resulting in bleaching of the heme.30,31
To alleviate this issue, different strategies have been explored such as enzyme

32

engineering,28,32–34 immobilization,35–37 or the development of in situ H2O2 production
methods,38,39 Among them, controlling the concentration of peroxide during the catalytic
reactions by employing in situ generation techniques provides a facile way to reduce the
peroxide-related enzyme inactivation.26,40,41 To date, photochemical and biological
approaches that generate H2O2 in a controlled manner have been reported to leverage OleT
enzyme catalysis. Zachos and colleagues described an in situ H2O2-generation system that
uses light to excite flavin cofactors with ethylenediaminetetraacetic acid (EDTA) as an
electron donor, which converts dioxygen to H2O2 to active the OleTJE enzyme for terminal
alkene production.42,43 Matthews et al. reported an enzyme genetic fusion system in which
OleTJE was linked to alditol oxidase (AldO). With this system, polyol substrates were fed
as AldO substrates to generate H2O2.44
In this work, we report the use of glucose oxidase (GOx) and sugars as substrates
to efficiently drive OleTSA catalysis in an adjustable manner (Figure 2.1b). GOx is a
flavoenzyme that metabolizes D-glucose by using molecular oxygen as an electron acceptor
with simultaneous production of H2O2.45 GOx is widely used in food, textile, and glucosesensing industries because of its high stability and catalytic efficiency.46 Other substrates
of GOx include D-mannose, D-galactose and

D-xylose,
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which are all abundant and

renewable feedstocks. Moreover, GOx has significantly varied kinetics with different
substrates,47,48 which enables one to regulate the H2O2-generating process. The data
presented in this manuscript demonstrates improved catalytic efficiency of OleT enzyme
when coupled with the GOx enzyme (the GOx method) compared to a single injection of
H2O2 (the H2O2 method). We rationalize that the GOx-based in situ H2O2-generation
method poises H2O2 concentrations at a level compatible with OleT catalysis while
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minimizing the heme destruction during the catalysis. Finally, we use a poly(4vinylpyridine) (P4VP) polymer to co-assemble GOx and OleTSA enzymes to generate
nanoparticles (NPs) in order to further optimize enzyme cascade catalytic efficiency. The
combination of the GOx-based method and the dual enzyme co-assembly with polymers
provides a novel way to leverage OleT enzyme catalysis, which can be potentially used for
synthetic applications.
2.2 EXPERIMENTAL SECTION
2.2.1 MATERIALS
GOx from Aspergillus niger and H2O2 were purchased from Sigma. Eicosanoic acid
(C20:0), stearic acid (C18:0), palmitic acid (C16:0), myristic acid (C14:0), lauric acid
(C12:0), and capric acid (C10:0) were purchased from BDH Chemicals. The alkene
standard 1-hexadecene was purchased from TCI chemicals. D-Glucose, D-mannose, Dgalactose were purchased from Fisher. Hydrocinnamic acid, 3-(4-bromophenyl) propionic
acid, indole-3-butyric acid, 3-(4-methoxyyphennyl) propionic acid and P4VP (Mw 60000)
were

purchased

from

Sigma-Aldrich.

N,O-Bis(trimethylsilyl)trifluoroacetamide

(BSTFA)/trimethylchlorosilane (TMCS) (99:1) were purchased from Supelco (Bellefonte,
PA, USA). Unless otherwise noted, all chemicals and solvents used were of analytical
grade and were used as received from commercial sources. Unless otherwise noted, 200
mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer.
2.2.2. HETEROLOGOUS EXPRESSION AND PURIFICATION OF OLETSA
The original OleTSA gene was synthesized and codon optimized for E. coli
expression by Bio Basic Inc. (Markham, Ontario). The gene was subcloned onto a
kanamycin-resistant T5 plasmid pJ401containing a C-terminal HisTag. The construct was
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transformed into BL21(DE3) containing the pTF2 plasmid encoding for GroEL/GroES/Tig
onto a kanamycin (50 μg/mL)/chloramphenicol (30 μg/mL) LB plate. Modified Terrific
Broth (TB) (24 g/L yeast extract, 12 g/L tryptone, 4 g/L peptone) supplemented with 50
μg/mL kanamycin and 20 μg/mL chloramphenicol was used to grow a cell culture from a
single colony overnight at 37 °C. For protein expression, 10 mL of this starter culture was
used to inoculate 500 mL of TB containing 50 μg/mL kanamycin, 30 μg/mL
chloramphenicol, 125 mg/L thiamine, and trace metals.22 The cultures were grown to an
OD600 nm of 1.0, at which point protein expression was induced with 100 μM IPTG, 10
ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid. The culture was incubated at 18
°C for an additional 16-18 h and harvested by centrifugation for purification or for storage
at -80 °C until further use. The protein was purified using nickel-nitriloacetic acid (NiNTA) affinity chromatography followed by Butyl-S-Sepharose column purification as
described previously.22 Fractions with an Rz value (Abs418 nm/Abs280 nm) above 1.2 were
pooled and dialyzed against 200 mM KPi pH 8. Proteins were stored at -80 °C until further
use. Enzyme purity was assessed by SDS-PAGE.
2.2.3. OLETSA ENZYME ACTIVITY ASSAYS
Eicosanoic acid and stearic acid stock (10 mM) were dissolved in 70% ethanol/30%
Triton X-100 (unless otherwise noted) as stocks. Other fatty acids including palmitic acid,
myristic acid and lauric acid were dissolved in DMSO to make 10 mM stocks.
Hydrocinnamic acid was dissolved in DMSO to make a 400 mM stock. To set up enzymatic
reactions, 5 μM OleTSA, 500 μM or 1 mM fatty acids or 1 mM hydrocinnamic acid (unless
otherwise noted) from above stocks were used for multiple-turnover reactions in a 150 μL
volume. H2O2 was added at a concentration of 2 mM to initiate the reactions in H2O2
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method, while 10 nM to 5 μM GOx was added to initiate the reactions in GOx method. Dglucose, D-mannose, or D-galactose (6.6 mM) were used in the GOx method unless
otherwise noted. The steady-state reactions were quenched with 0.4 mM HCl or 1% acetic
acid for GC/GC-MS or LC/LC-MS analysis, respectively.
2.2.4. HEME DECAY MONITORING
Heme decay was monitored with UV-Visible spectroscopy on an HP 8453
spectrophotometer. A quartz cuvette with 1 cm path length was used. For the heme decay
monitoring during GOx- or H2O2-driven reactions, 5 μM OleTSA, 0.5 mM eicosanoic acid
in the presence of 2 mM H2O2 or 10 nM GOx and 6.6 mM glucose were used. OleTSA
spectra were recorded over time for 1 h at room temperature. Active enzyme concentration
was determined from the total thiolate-ligated heme in the sample, based on the extinction
coefficients of the Soret peaks: at 418 nm, 112.8 mM-1cm-1 for low-spin fraction, 56.6 mM1

cm-1 for high-spin fraction; 86.8 mM-1cm-1 at 406 nm; at 394 nm, 50 mM-1cm-1 for low-

spin fraction, 106.5 mM-1cm-1 for high-spin fraction.22
2.2.5. GAS CHROMATOGRAPHY (GC) ANALYSIS
For gas chromatographic quantification of fatty acid metabolism by OleTSA,
internal standards including 1-hexadecene and a Cn-2 fatty acid (relative to substrate of
chain-length Cn) were added after the reactions were quenched with 300 mM HCl. The
reactions were extracted with 300 μL chloroform. The organic phases of each reaction were
tested on GC directly or derivatized before GC analysis. For derivatization, samples were
concentrated under a stream of N2 gas to less than 50 μL, then derivatized with 250 molar
equivalents of BSTFA: TMCS (99:1). Samples were incubated at 60 °C for 20 minutes for
trimethylsilylation. Following the derivatization, samples were analyzed by GC. The
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following oven conditions were used to detect products of C20 through C16 fatty acids:
170 °C for 3 min, 10 °C/min to 220 °C, 5 °C/min to 320 °C, and 320 °C for 3 min. The
following oven conditions were used to detect products of C14 and C12 fatty acids
metabolism: 100 °C for 3 min, 5 °C/min to 250 °C and 250 °C for 3 min. The response
factors between fatty acids, hydroxyl fatty acids and alkenes were determined by analyzing
known authentic fatty acids (C18-C10) and 1-hexadecene standards.
2.2.6. HPLC AND MS ANALYSIS
Reactions (total volume = 150 μL) with hydrocinnamic acid were quenched by
acetic acid (final concentration 1% v/v). After quenching, 1,2,3,4-tetramethyl benzene was
added as internal control and the mixture was extracted with ethyl acetate (300 μL). For
each sample, 20 μL of organic layer was were injected in an Agilent 1100 HPLC equipped
with a ZORBAX SB-C18 column. HPLC parameters were as follows: 25 °C; solvent A,
1% acetic acid in water; solvent B, methanol; gradient, 10% B for 2 min; then, from 10%
B to 100% B over 32 min; then, from 100% B to 10% B over 10 min, flow rate, 0.5 mL/min.
Detection of the products was by UV absorbance at 250 nm. Quantification of product was
calculated from a calibration curve of styrene with the same extraction method. The
identity of the styrene product was confirmed by LC-MS at the Mass Spectrometry Center,
University of South Carolina.
2.2.7.
SYNTHESIS
CHARACTERIZATION

OF

P4VP-GOX-OLETSA

ASSEMBLIES

AND

A solution of P4VP in ethanol (2.5 mg·mL-1, 0.1 mL) was slowly added to a
solution containing 1 µM OleTSA and 1 µM GOx in buffer A (0.9 mL) with stirring. After
addition, the mixture was stirred for an additional 10 min for equilibration. Because of the

37

high loading capacity,49 the co-assemblies was not purified before characterization and
activity test. The size distribution of P4VP-GOx-OleT assemblies were measured with
dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). For TEM
analysis, P4VP-GOx-OleT samples prepared above were diluted 10 times with water, and
20 μL of diluted samples were dropped onto 250-mesh carbon-coated copper grids and
dried. The grids were observed with a Hitachi H-8000 electron microscope at the Electron
Microscopy Center, University of South Carolina.
2.2.8. ACTIVITY COMPARISON OF P4VP-GOX-OLETSA ASSEMBLIES AND FREE
GOX/OLET ENZYME CASCADE
The activities of both P4VP-GOx-OleTSA and free enzyme cascade were assessed
in a reaction volume of 250 μL containing GOx and OleTSA (1 μM/each), hydrocinnamic
acid (2 mM) or myristic acid (1 mM). Reactions were initiated by the addition of mannose
(6.6 mM) to the reaction mixture and incubated at room temperature (23 – 25°C). In the
control reactions, GOx and mannose were omitted from the reaction sample and instead, 2
mM H2O2 was used to initiate the reactions. A stock solution of 400 mM hydrocinnamic
acid was prepared in DMSO. The final organic solvent concentration in the reaction is
4.1% ethanol and 1% DMSO for each sample. The reaction was quenched by the addition
of 1% acetic acid, and an internal standard of 1,2,3,4-tetramethyl benzene was added. The
products were exacted with 300 μL ethyl acetate and analyzed by LC or GC as described
above.
2.2.9. CATALASE COMPETITION ASSAY
Catalase, as a scavenger for H2O2, was added to the enzymatic reactions catalyzed
by assembled enzyme cascade (P4VP-GOx-OleTSA) and free GOx/OleTSA to measure the
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differences. A serial concentration of catalase from 15.6 nM to 250 nM was added into the
reaction mixtures containing GOx and OleTSA (1 μM/each), hydrocinnamic acid (2 mM),
and mannose (6.6 mM). As above, the reactions were initiated by the addition of mannose
and quenched by the addition of 1% acetic acid, and 1,2,3,4-tetramethyl benzene was added
as internal standard. The reactions were exacted by 300 μL ethyl acetate and analyzed by
LC.
2.3 RESULTS AND DISCUSSION
2.3.1 H2O2 CONCENTRATION DEPENDENCE OF OLETSA ACTIVITY AND HEME
BLEACHING
OleTSA enzyme was purified using Ni column affinity chromatography followed
by hydrophobic interaction chromatography (Butyl-Sepharose) (Figure 2.2). As shown in
Figure 2.3a, a certain level of H2O2 is necessary to drive OleTSA enzymatic catalysis to
form oxidizing species known as Compound I. However, with excess H2O2, the enzyme
displays low substrate conversion,41,50 suggesting peroxide-mediated enzyme inactivation.
To characterize the H2O2 concentration dependence of OleTSA enzymatic activity, varying
concentrations of H2O2 were added in the enzyme reaction with eicosanoic acid as the
substrate. Nonadecene production (which is the sole product of eicosanoic acid reaction)22
was used to calculate the product conversion rate. As shown in Figure 2.3a, with increasing
H2O2 concentration from 0.05 mM to 2 mM, increased conversions from 4% to 12% were
obtained. On the other hand, increasing the H2O2 concentration further from 2 mM to 40
mM led to a decreased conversion. A similar trend was also observed for OleTSA-catalyzed
styrene production using hydrocinnamic acid as substrate (Figure 2.4). These results
demonstrate that the H2O2 concentration has a dramatic effect on OleTSA catalytic
efficiency.
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Figure 2.2 SDS-PAGE gel of the purified OleTSA

Figure 2.3 The H2O2 concentration dependence of OleTSA enzyme activity (a) and the
Soret band intensity (b-c). (a) Comparison of the reaction rate of the conversion of
eicosanoic acid to nonadecene by OleTSA with various H2O2 concentrations. The reaction
conditions are as follows: OleTSA 5 μM, eicosanoic acid 1 mM, H2O2 0.05 mM - 40 mM,
room temperature for 30 min. Error bars indicate the standard deviation of two independent
experiments (n = 2). (b) The UV-Vis spectra of 5 μM OleTSA was recorded immediately
after adding varying concentrations of H2O2. The arrow indicates the increase of H2O2
concentration. (c) Absorbance monitoring of 5 μM OleTSA treated with 2 mM H2O2 from
20 s to 60 min. The arrow indicates the increase of incubation time. (d) The UV-Vis spectra
of 5 μM OleTSA was recorded after treating with varying concentrations of H2O2 for 15
min. (f) The UV-Vis spectra of 5 μM OleTSA was recorded after treating with varying
concentrations of H2O2 for 30 min. Protein aggregation was observed with high
concentration of H2O2 treatment and longer time incubation, which causes high scattering.
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Figure 2.4 H2O2 concentration dependence test for OleTSA catalysis with hydrocinnamic
acid. Reaction condition: OleTSA 5 μM, hydrocinnamic acid 4 mM, reaction at room
temperature for 60 minutes.
The destruction of the heme group of P450s and unspecific peroxygenases by H2O2
or other reactive intermediates such as superoxide anion (O2-) and hydroxyl radical (•OH)
has been widely reported.29,51,31 Because the intact heme has prominent optical features,
heme degradation can be easily monitored by the loss of these features.31 In the low-spin
ferric resting state, the most intense optical peak of P450s is the Soret band, which is
centered at 418 nm for substrate-free low-spin OleTSA.22,24 As shown in Figure 2.3b, upon
the injection of increasing concentrations of H2O2 from 0.05 mM to 40 mM, the Soret band
absorption of OleTSA decreases, implying heme destruction with H2O2 treatment. More
serious heme bleaching and protein precipitation occurs upon longer incubation with high
concentration of H2O2 (Figure 2.3d and 2.3e). Even with 2 mM H2O2, a condition in which
the enzyme shows maximized conversion rate (Figure 2.2a), significant heme bleaching
can be observed over time in Figure 2.3c. These results suggest that heme destruction is a
key factor that limits OleTSA catalysis, and thus maintaining a compatible H2O2
concentration during the reaction could potentially improve OleTSA catalytic efficiency.
Slow H2O2 perfusion or fed-batch method have been used to circumvent the heme issue.41,23
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In this contribution, we propose to use a GOx enzyme-based in situ H2O2-generating
method to leverage OleTSA catalysis.
2.3.2 EFFECT OF DIFFERENT GOX SUBSTRATES ON THE ENZYME CASCADE
CATALYSIS
It has been reported that GOx not only efficiently oxidizes D-glucose but also
consumes different sugars including D-mannose, D-galactose and D-xylose among others
with slower reaction rates,47,48,52 which provides a useful method to tune the rate of H2O2generation to better optimize OleT catalysis. To maximize the potential of a multi-enzyme
system, kinetic matching of each enzymatic reaction is important.53–55 In order to optimize
the stoichiometry of GOx and OleTSA in the tandem catalysis reaction, different
concentrations of GOx were tested with fixed concentrations of OleTSA and varying sugar
substrates. As shown in Figure 2.5a, with glucose as a substrate, 10 nM GOx (0.002 molar
equivalents to OleTSA) leads to maximized substrate conversion. Upon further increasing
the GOx concentration, the product yield decreased, which could be caused by enzyme
inactivation due to excess H2O2 produced from the GOx/glucose reaction. When mannose
or galactose was used, at least one molar equivalent of GOx to OleTSA was needed to
maximize the conversion rate. A similar phenomenon was observed in the assay where
hydrocinnamic acid was metabolized by OleTSA to produce styrene (Figure 2.6). However,
it is noteworthy that upon increasing the mannose concentration up to 13 mM, styrene
production continued to rise (a ~30-50% increase, depending on the different GOx
concentration) (Figure 2.6 inset).
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Figure 2.5 OleTSA catalysis can be driven by different sugars with optimized GOx enzyme
concentration. (a) Comparison of the conversion of eicosanoic acid with the OleTSA/GOx
catalysis in a 60 min reaction time. (b) A time course comparison with GOx_Glucose and
GOx_Mannose as H2O2 source vs. direct addition of H2O2 (2 mM). An exponential model
was used to fit the data in (b). Reaction conditions were as follows: OleTSA 5 μM, sugars
6.6 mM, eicosanoic acid 1 mM, GOx (concentrations as indicated) at room temperature.
Error bars indicate the standard deviation of duplicate experiments (n = 2).
A typical time course of product formation with the optimized GOx/OleT ratio is
shown in Figure 2.3b. Decarboxylation continues to proceed until the end of the test (2
hours) in the GOx method, demonstrating clear advantages of enzyme utility by comparing
with that in the H2O2 method. As a control, a glucose titration test with GOx method shows
increasing OleTSA activity with increasing glucose concentration, while with H2O2 method,
glucose had no such effect, indicating that the enhancement of activity by glucose only
occurs when paired with GOx (Figure 2.7). It is apparent that controlling the in situ H2O2generation rate to maintain an appropriate H2O2 level during OleTSA catalysis is important
to maximize its enzymatic conversion. In summary, the GOx method shows significantly
improved OleTSA catalytic efficiency than the H2O2 method, while GOx enzyme pairing
with different sugars makes the method flexible to leverage OleT enzyme catalysis. Based
on this, we demonstrated the kinetic matching of the tandem catalysis may be an important
parameter to optimize the enzyme cascade efficiency.
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2.3.3. GOX/OLETSA ENZYME CASCADE CATALYSIS TEST WITH DIFFERENT
FATTY ACIDS
Abundant and bioavailable fatty acids provide a renewable source for the
sustainable production of terminal alkenes. To improve conversion yield has been a major
pursuit for the OleT enzyme’s application.14,44 Here, we tested the GOx/OleTSA enzyme
cascade activity with a selection of fatty acids including eicosanoic acid, stearic acid,
palmitic acid, myristic acid and lauric acid using glucose as a GOx substrate at the
optimized condition (molar ratio of GOx:OleTSA = 1:500) as described above. By
comparison to the one-time H2O2 injection method, GOx method exhibits 25% to 300%
higher conversion of substrate to product depending on the fatty acid substrate used (Table
2.1). The chemo-specificity of enzymatic catalysis was similar in both two methods of
peroxide addition (Table 2.2). In addition, with long-term reactions, the GOx method
showed further increased substrates conversion, while there was no improvement with time
in the H2O2 method (Table 2.3), which supports our hypothesis the function of OleTSA is
irreversibly hampered by a high-volume addition of H2O2. By comparing different methods
used for the OleT enzymatic reaction reported in literature so far, our method provides a
simple and efficient way to improve the enzyme catalysis (Table 2.4).
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Figure 2.6 OleTSA catalysis can be driven by different sugars in presence of different
concentration of GOx enzyme. Reaction condition: OleTSA 5 μM, sugars 6.6 mM,
hydrocinnamic acid 4 mM, room temperature for 60 minutes. 2 mM H2O2 was used in the
H2O2 method as control. Inset: GOx titration test with 13 mM mannose and 4 mM
hydrocinnamic acid at room temperature for 60 minutes.

Figure 2.7 Glucose titration with GOx method. Reaction condition: OleTSA 5 μM,
eicosanoic acid 1mM at room temperature, 30 minutes. Same operation was done with
H2O2 method to exclude the glucose effect on the enzyme activity.
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Table 2.1 OleTSA metabolic profile with different FAs with either the GOx or H2O2
method.
Conv.
Substrate
Method
Alkene (%) Alcohol (%)
(%)
eicosanoic acid*

stearic acid*

GOx

>99

NA

50 ± 5

H2O2

>99

NA

12 ± 2

GOx

>99

<1

71 ± 3

H2O2

>99

<1

57 ± 1

GOx

62

38

93 ± 7

H2O2

49

51

23 ± 4

GOx

63

37

99 ± 3

H2O2

60

40

75 ± 5

GOx

59

41

92 ± 7

H2O2

50

50

71 ± 5

palmitic acid

myristic acid

lauric acid
Reaction conditions are as follows: 5 μM OleTSA, 0.5 mM fatty acid substrate, and either
0.01 μM GOx with 6.6 mM glucose or 2 mM H2O2. The reaction was in a total volume of
300 μL and carried out at room temperature for 60 min. *The C20 and C18 fatty acid was
dissolved in 70% ethanol/30% triton-100 as stock. All other fatty acids were dissolved in
DMSO as stock.
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Table 2.2 OleTSA metabolized alcohol products profile comparison with the GOx methoda
and H2O2 methodb 22
Substrate
Method
Alcohol (%)
eicosanoic acid

stearic acid

palmitic acid

myristic acid

lauric acid

GOx

NA

H2O2

NA

GOx

<1%

H2O2

<1%

GOx

8% α, 63% β, 29% γ

H2O2

3% α, 97% β, NA γ

GOx

26% α, 75% β, γ NA

H2O2

19% α, 81% β, γ NA

GOx

11% α, 73% β, 16% γ

H2O2

4% α, 96% β, γ NA

Reaction condition: OleTSA 5 μM, FAs 500 μM, 10 nM GOx, 6.6 mM glucose for 1
hour. Alcohol products distribution was calculated based on the according peak areas.
b
Reaction condition: OleTSA 5 μM, FAs 500 μM. 5 mM H2O2 was perfused with pump
within 2 hours. The Cβ regiospecificity is defined as the fractional percentage of alkenes
and Cβ-alcohols over total products formed by the enzyme.
a
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Table 2.3 OleTSA metabolism profile with different FAs with GOx and H2O2 method for
overnight reactions
Substrate
Method
Alkene (%) Alcohol (%) Conv. (%)
eicosanoic acid*

stearic acid

palmitic acid

myristic acid

lauric acid

GOx

>99%

NA

>99%

H2O2

>99%

NA

13 ± 4

GOx

>99%

<1%

35 ± 2

H2O2

>99%

<1%

3 ± 1*

GOx

63

37

94 ± 3

H2O2

41

59

35 ± 1

GOx

79

21

>99%

H2O2

60

40

81 ± 3

GOx

74

26

>99%

H2O2

47

53

75 ± 13

Condition: OleTSA 5 μM, substrate 0.5 mM, GOx 0.01 μM, glucose 6.6 mM or H2O2 2
mM, 300 μL reaction at room temperature for overnight. * The C20 fatty acid was
dissolved in 70% ethanol/30% triton-100 as stock. All other fatty acids were dissolved in
DMSO as stock.
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Table 2.4 Comparison of the catalytic efficiency GOx/OleTSA enzyme cascade and other
reported systems
Entry

Enzym
e

Enzyme [μM]/
Substrate
[mM]

Method/
Electron
source

1

OleTJE

5/0.5 (C14:0)

OleT-AldO
fusion/glycerol

RT, 20
min

95

38

2

OleTJE

2/0.5 (C20:0)

light-driven

25 °C, 2 h

25

39

3

OleTJE

3/1 (C20:0)

RT, 12 h

233

14

4

OleTJE

1.5/5 (C18:0)

RT, 170
rpm, 24 h

2096

15

5

OleTJE

1/0.5 (C20:0)

H2O2 perfusion

RT, 1 h

280

18

6

OleTSA

5/0.5 (C14:0)

H2O2 fed-batch

30 °C, 12
h

94

20

OleTBM3R/NADP
H
OleT/FDHCamAB/
NADPH

Turnove
Reaction
r number
conditions
(TON)

Ref.

OleT/GOx
This
cascade/glucos
RT, 2 h
96
study
e
OleT/GOx
This
8
OleTSA
1/1 (C20:0)
cascade/glucos RT, 12 h
410
study
e
In entry 3 and 4, a dehydrogenase-based NADPH regeneration system was coupled. In
entry 8, the molar ratio of OleT to GOx was kept as 500:1.
7

OleTSA

5/1 (C20:0)

2.3.4. HEME DESTRUCTION IS PREVENTED USING THE GOX METHOD OF H2O2
ADDITION
The improved OleTSA enzyme catalytic activity with GOx method was attributed
to a gradual and robust production of H2O2 that prevents heme degradation during the
tandem catalysis. To confirm this hypothesis, OleTSA spectra were monitored during the
enzymatic reactions with either one-time H2O2 addition or the gradual introduction using
GOx (Figure 2.8a and 2.8b). The Soret peak was used as a handle for monitoring heme

49

integrity. As expected, OleTSA enzyme shifts from the high-spin (substrate-bound) state to
the low-spin (substrate-free/product-bound) state spontaneously upon treatment with 2 mM
H2O2, and stays predominantly in this state for the remainder of the time course test. We
have previously determined in OleTJE that product release is significantly slower than the
chemical steps (e.g. H2O2 activation, C-H abstraction) that lead to alkene generation,56
consistent with the spectra obtained here. Within minutes, the heme chromophore bleaches
during the H2O2 treatment. On the other hand, with the GOx method, the low-spin Soret
maximum at 418 nm appears after 5 min of reaction, indicating most of the proteins are
substrate-free/product-bound like that of the H2O2 method, which suggests there is a burst
of H2O2 during this period. Then, the enzyme returns to predominantly high-spin state for
the remainder of the assay. This indicates that the majority of the OleTSA is in the substratebound state and that H2O2 production by GOx is now rate-limiting. And the sluggishness
of peroxide generation protects the heme from H2O2-mediated degradation to afford the
higher overall turnover numbers shown above. As quantitative confirmation, the Soret peak
intensity (as the sum of high-spin and low-spin) was used to determine the fraction of active
enzyme throughout the time course study. As shown in Figure 2.8c, more than half of
enzyme was inactivated within 1 h in the H2O2 method, whereas with the GOx method, the
amount of active OleTSA enzyme remained unchanged after 1 hour, which is consistent
with the observation that OleTSA is continually active during this time period (Figure 2.5b).
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Figure 2.8 Soret band monitoring during OleTSA catalytic reactions with H2O2 method (a)
and GOx method (b). In all reactions, 5 μM OleTSA, 0.5 mM eicosanoic acid, 2 mM H2O2
or 10 nM GOx, 6.6 mM glucose were used. (c) Active OleTSA enzyme fraction comparison
during the catalytic reactions with GOx and H2O2 methods.
2.3.5. POLYMER-GOX-OLETSA ASSEMBLY TO IMPROVE ENZYME CASCADE
CATALYTIC EFFICIENCY
Inspired by natural multienzyme complexes that exhibit extraordinary
efficiency,57,58 a variety of enzyme cascades have recently been developed via colocalization of enzymes on nanostructured scaffolds59–67 to enable cooperative catalytic
mechanisms such as facilitating intermediate transportation,59,60 kinetic modification via
enzyme or intermediate substrate scaffold interactions,59,63 stoichiometry optimization,61
and encapsulation,65,66 etc. We therefore attempted to co-assemble GOx/OleTSA enzyme
pairs on a polymeric support to further promote enzymatic catalysis. In our previous
studies, we used P4VP and other polymers to co-assemble different proteins to generate
core-shell nanoparticles (NPs) 48,64,65,66 and demonstrated a high protein loading capacity
and a close proximity of proteins on the surface of the NPs.49,71 Both the fine balance
between hydrophobicity and hydrophilicity as well as the hydrogen bonding between
proteins and polymers provide a benign environment for proteins to maintain their
functions. Herein, we use this strategy to co-assemble GOx and OleTSA enzymes (Figure
2.9a) in order to improve the enzyme cascade catalytic efficiency. With the assumption
that the two enzymes have equal chance to attach to the NPs surface, equal molar
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concentration of GOx and OleTSA (1 μM/each enzyme) was used for the co-assembly. TEM
and DLS analysis shows successfully assembled polymer-dual-enzymes NPS with an
average size of ~385 nm (Figure 2.9c). For tandem catalytic reactions, mannose was fed,
hydrocinnamic acid or myristic acid was used as an OleTSA substrate to compare the
activity of the assemblies to enzymes in solution. As shown in Figure 2.9d and Figure
2.10, P4VP-GOx-OleTSA assemblies exhibit around 35-40% higher activity than the free
GOx/OleTSA in a 60-min reaction at room temperature with different OleTSA substrates.
As a control, the mixture of P4VP-GOx and P4VP-OleTSA assemblies showed
comparable activity with the free enzymes (Figure 2.9d). Moreover, with dilutions, the
co-assembled samples showed further enhanced activity compared to the free enzymes (~
60% enhanced activity was observed with 5 × times dilution of each sample, Figure 2.11).
These results suggest that improved activity of the co-assemblies is related to the closed
space of enzymes because of the co-localization on the NPs. In addition, if H2O2 instead of
mannose was used to drive the catalysis, P4VP-GOx-OleTSA did not exhibit any enhanced
activity comparing to the free enzymes (Figure 2.12).
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Figure 2.9 (a) Schematic illustration of the preparation of P4VP-GOx-OleTSA in
buffer/ethanol co-solvent. (b) Model of H2O2 diffusion on the surface of P4VP-GOxOleTSA assemblies. The pink color represents hydration layer on the NPs surface. (c) TEM
image of P4VP-GOx-OleTSA assemblies; inset: DLS analysis shows the size distribution
of P4VP-GOx-OleTSA assemblies. (d) P4VP-GOx-OleTSA assemblies show enhanced
activity than free enzyme cascade for styrene production with 6.6 mM mannose as sugar
source, and 2 mM hydrocinnamic acid as the substrate. An exponential model was used to
fit the data. (e) Inhibition effect of catalase on the reactions catalyzed by P4VP-GOxOleTSA and free GOx/OleTSA mixtures. The reaction condition was the same as in (d) and
were quenched after 60 minutes’ incubation. Error bars indicate the standard deviation of
duplicate experiments (n = 2).

Figure 2.10 (a) P4VP-GOx-OleTSA assemblies show enhanced activity than free enzyme
cascade for C13 alkene production. Myristic acid (1 mM) was used as the substrate and
mannose (6.6 mM) was fed in the reaction. (b) GC spectrum of the activity comparison.
C16 alkene (150 μM) was used as internal standard at 18.4 min.
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Figure 2.11 Activity enhancement was enlarged with dilution of P4VP-GOx-OleTSA NPs
and free GOx/OleTSA solution. (a) Styrene production test of the samples with different
dilutions. Condition: GOx and OleTSA (1 μM/each), hydrocinnamic acid (2 mM), Mannose
(6.6 mM) in 500 μL reactions were used for all samples. 0.2 mg/mL P4VP was used for
the co-assembly. Inset: the pictures of P4VP-GOx-OleTSA samples with different dilutions.
The clean tubes contain free enzymes reactions. The cloudy tubes contain P4VP-GOxOleTSA assemblies catalyzed reactions. The pictures were taken after the 2 hours’ reaction
at RT. (b) Activity comparison of P4VP-GOx-OleTSA samples and free GOx/OleTSA
samples with different dilutions.

Figure 2.12 Activity comparison of P4VP-GOx-OleTSA assemblies and free enzyme
cascade with H2O2 method. hydrocinnamic acid (4 mM) was used as substrate. H2O2 (2
mM) was used with 30 minutes’ reaction. Error bars indicate the standard deviation of
duplicate experiments (n =2).
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To further confirm whether the activity enhancement is due to proximity effects,
catalase, a scavenger of H2O2, was added to challenge the tandem catalysis. As shown in
Figure 2.9e, the reactions catalyzed by P4VP-GOx-OleTSA was much less inhibited by
catalase than that of free enzymes. For example, when 250 nM of catalase was included in
the reactions, P4VP-GOx-OleTSA still showed ~30% activity, while only 15% activity was
observed for free enzymes. This result suggests that on the surface of NP assemblies, some
H2O2 produced by GOx is transferred to OleTSA directly and is not freely defused into the
bulk solution due to the closed proximity of the enzymes. We rationalize that in this system,
large amount of enzyme pairs assembled on the nanoparticles surface may provide multiple
local targets for H2O2.72,73 Moreover, the very closed distance of the enzymes may create
a hydration layer74 on the surface of NPs, which facilitates H2O2 transportation among
enzymes,59 making a high local concentration of H2O2 around the OleTSA enzymes. All
these factors may contribute to the enhanced GOx/OleTSA enzymatic activity when adhered
to NP surfaces. However, the modest activity improvement and the slight sensitivity to
catalase suggest the assembly is unable to directly tunnel H2O2 (Figure 2.9b), which could
be the reason why only a relatively weak enhancement compared to other encapsulation
systems.65,75 Nevertheless, the combination of the GOx-driven OleTSA catalysis and the colocalization of the enzyme pairs on polymeric NPs through co-assembly demonstrated an
efficient way to improve the cascade enzymatic catalysis.
2.4. CONCLUSION
In this study, we report the use of a GOx enzyme-based in situ H2O2-generating
method to drive OleTSA catalysis to produce terminal alkenes with significantly improved
substrate conversion than the one-time addition of peroxide. By monitoring the heme using
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UV-visible spectroscopy during the reaction, we confirmed that the enhancement was due
to the minimized heme degradation in the GOx method. By adjusting the GOx/OleTSA
molar ratio and using different sugars, our system provides a flexible method to tune the
H2O2-generating process and thus to leverage the catalysis of OleTSA. In particular, when
glucose is used, only 0.002 molar equivalents of GOx are required to efficiently drive
OleTSA catalysis. This not only demonstrates a simple approach to improve the isolated
OleT enzyme catalysis in vitro but also provides new perspective for alkene production in
vivo.76–78 With this enzyme cascade model, a facile P4VP polymer-dual enzyme coassembly was developed to further optimize the enzyme cascade catalytic efficiency
through enzyme co-localization. Overall, the GOx-based in situ H2O2-generation method
with OleTSA represents a simple and efficient strategy to transform bioavailable feed stocks
such as fatty acids to industrially important chemicals.
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CHAPTER 3
MICROFLUIDIC-ASSISTED POLYMER-PROTEIN ASSEMBLY TO FABRICATE
HOMOGENEOUS FUNCTIONAL NANOPARTICLES
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3.1. INTRODUCTION
Polymeric nanoparticles (PNPs), because of their small size, high surface-area-tovolume ratio, and easy tunable physical and chemical properties, have gained great
attentions in materials science.1,2 Through chemical modification of polymer chains3 or
conjugation with distinct functional molecules ( e.g. inorganic or organic molecules, lipids,
peptides, and proteins),4–8 PNPs could be tailored with customized properties, and were
found numerous applications in the fields of medicine,9 bioimaging,10 sensing11,12 and
catalysis.13,14 Among them, the controlled assembly of polymers and/or proteins via
supramolecular interactions offers unique opportunity in understanding the spontaneously
self-organization process and fabrication of bioactive PNPs.15–21 Currently PNPs are
usually prepared using standard bulk reaction conditions,22–26 which generally lead to large
variability in their size distribution. In fact, it remains difficult to reproducibly synthesize
batches of homogenous PNPs in bulk reactors, primarily due to the uncontrolled and
insufficient mixing in addition to the uncontrolled residence time during the PNPs
formation.27 Therefore, methods that provide precise control of PNPs size distribution (for
example, through microfluidics by optimizing mass transfer kinetics and diffusion rates,
etc.) are of high interests.28–30
In our previous work, we systematically studied the co-assembly of poly(4vinylpuridine) (P4VP) or other pyridine group grafted polymers with functional proteins
to form core-shell PNPs.21,31–34 The synthesis involved the mixing of polymer with protein
in bulk reactors to form NPs intermediates, followed by dialysis or organic solvent
evaporation for NPs maturation (Figure 3.1a). The assembly is primarily controlled by a
kinetic process driven by the reduction of interfacial tension, i.e., the polymer forms
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aggregates when experiencing non-solvents. After this nucleation step, proteins, acting as
a surfactant-like role, are absorbed on the surface to stabilize the NPs. We hypothesize the
protein is a relative slower step compared to the fast nucleation during the co-assembly.
Both the fine balance between hydrophobicity and hydrophilicity as well as the hydrogen
bonding between proteins and polymers are necessary for a successful co-assembly.21
Nevertheless, because of the insufficient and less controllable mixing in bulk reactors, the
polymer and polymer-protein particles experienced heterogeneous solvent environment
during co-assembly, resulting in a broad size distribution of the NPs.21,31,33

Figure 3.1 (a) Schematic illustration of proposed polymer-protein co-assembly process.
(b) Schematic illustration of the entrance of microchannel which is used for polymer
protein co-assembly. The fluids with different electrical conductivity (σ1 & σ2) in the nonparallel microchannel are driven by the hydrodynamic force fh and the flow is excited by
the electrical body force fe which can be divided into x-components fex and y-component
fey. fex at different points along the electric line can be either negative or positive related to
fh. The large force in x-direction (fh + fex) and y-direction fey can generate a shear stress and
produce a micro vertex,38 resulting in ultrafast mixing.
Using microfluidics based microreactor to synthesize various functional
nanoparticles has attracted attentions because of its unique advantages, such as controllable
transportation at microscale, significantly reduced diffusion distance, etc.35 With improved
diffusion process via geometrical design, microfluidics based mixers have been used for
synthetic purposes.29,36,37 However, because normally Reynolds number is low in
microfluidic devices, the flow is laminar and the corresponding mixing is conducted only
through a molecular diffusion process, and thus is relatively slow and poor. For this reason,
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Dr. Guiren Wang’s group has developed a method to generate turbulent-like flows to create
ultrafast mixing in microfluidic system under electrokinetics (EK) forcing,38,39 which
provides new opportunities for flow control and manipulation in microfluidics. In
particular, it was found that rapid mixing could be achieved on both large and small scales
in the majority of the microchannel under AC electric field.38 For example, with a 20 Vp-p
voltage and 2 μL/min flow rate, 77% mixing can be reached within 5 milliseconds (ms),40
which is much faster than other reported EK based micromixers.41,42 Moreover, the mixing
process could be easily controlled and fine-tuned by adjusting the AC electric fields (e.g.
voltage, frequency, signal phase shift) and flow rates,43 which makes it a superior technique
than conventional geometry based micro mixers regarding to controllable mixing
manipulation.
Herein, for the first time, we report the usage of this EK based microfluidic method
(Figure 3.1b) to achieve polymer-protein co-assembly in order to fabricate homogeneous
polymer-protein nanoparticles. Nanoparticle size is the result of two competing processes:
drop breakage and coalescence after nucleation.44 In our system, when protein stream and
polymer dissolved ethanol stream meet in the microchannel, polymer droplets between
the two phases of fluids will form at the initial stage and can then coalesce. The EK flow
induced shear stress may breakup larger drops to generate smaller ones to increase
interfacial area, and thus to enhance molecular mixing. The particle size distribution
depends not only on the dispersive and continuous phase properties, the presence of
surface-active agents, the type of surfactants, and the presence of electrolytes, but also on
the overall flow velocity and concentration fields. Therefore, in this contribution, different
proteins, flow rates and protein/polymer mass ratios were tested for the co-assembly via
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fast mixing of micro fluids. We demonstrate that the polymer-protein NPs fabricated using
our microfluidic method are highly uniform, the NPs size is tunable, and proteins’ function
is well retained. Because it is much easier to scale up by parallelization of multiple channels
compared to the bulk method, this EK-based microfluidic method has unique advantages
in its application for polymer protein co-assembly.
3.2. THEORY
The principle of generating chaotic EK flow and mixing is given below to illustrate
qualitatively how the mixing is enhanced. There is an initial large electrical force that can
overcome viscous force to generate strong chaotic flows. The Navier-Stokes equation with
EK force can be described as
𝜌(𝜕𝑢⁄𝜕𝑡 + 𝑢 ∙ 𝛻𝑢) = 𝛻𝑝 + 𝜇𝛻 2 𝑢 + 𝐹𝑒
1

1

2

2

𝐹𝑒 = 𝜌𝑓 𝐸 − (𝐸 ∙ 𝐸)∇𝜀 +

(1)
𝜕𝜀

∇ [𝜌𝐸 ∙ 𝐸 ( ) 𝑇]

𝜌𝑓 = ∇ ∙ (𝜀𝐸) = ∇𝜀 ∙ 𝐸 + 𝜀∇ ∙ 𝐸

𝜕𝜌

(2)
(3)

where ρ, 𝑢 , p, μ are the fluid density, flow velocity, pressure and dynamic viscosity
respectively; 𝐹𝑒 is electrical body force, which consists of the Coulomb force (1st term),
dielectric force (2nd term) and thermal expansion (3rd term) respectively in Eq. (2); 𝐸 is
electric field, 𝜌𝑓 is the free volume charge density; 𝜀 and σ are the electric permittivity and
conductivity of the electrolyte respectively, and T indicates temperature. For
incompressible fluids, the third term can generally be ignored.45 In addition, for a given
fluid, 𝜀 mainly depends on T. On the one hand, as the two initial streams with different
conductivity σ meet together, the interface between the two streams can be assumed to be
frozen within a very short distance before the electrokinetic flow starts to develop. On the
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other hand, the bulk flow and the generated strong mixing will also transfer potential heat
caused by Joule heating to downstream and to the good heat conductive metal walls.
Therefore, T variation due to electrothermal effects could be insignificant. Thus 𝜀 is
assumed to be uniform in the flow, 𝜕𝜀⁄𝜕𝑡 ≈ 0 and ∇𝜀 ≈ 0. So the second term force in
Eq. (2) is also negligible. Then we have
𝐹𝑒 = 𝜌𝑓 𝐸

(4)

The transport equation of 𝜌𝑓 for a bipolar system is: 45
𝜕𝜌𝑓
𝜕𝑡

+ 𝑢 ∙ ∇𝜌𝑓 + ∇ ∙ (𝜎𝐸) = (

𝐷+ −𝐷−

𝑚+ +𝑚−

) ∇2 𝜎 + (

𝐷+ 𝑚+ +𝐷− 𝑚−
𝑚+ +𝑚−

) ∇2 𝜌𝑓

(5)

where 𝜎 is the conductivity of the fluid, 𝑚+ and 𝑚− and 𝐷+ and 𝐷− are the mobility and
diffusivity of positive and negative charges respectively. Since in liquid, Schmidt number
is usually very large, to simplify the process to illustrate the major physics, the diffusion
term can be negligible. Because of the large conductivity different between the two
streams, 𝐸 will generate 𝜌𝑓 near the interface, and the transport of 𝜌𝑓 is primarily
dominated by 𝐸, and thus, the convection 𝑢 is relatively negligible. Then Eq. (5) can be
simplified as:
𝜕𝜌𝑓 ⁄𝜕𝑡 + ∇ ∙ (𝜎𝐸) = 0

(6)

Note although based on electro neutrality assumption, which is often adopted for transport
phenomena in electrolyte, ∇ ∙ (𝜎𝐸) = 0, such an approximation is not applicable here, not
only because the well-known reasons described by Probstein,46 but also because of the 𝜌𝑓
created at the interface with a large difference in the conductivity between the two streams
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as shown in Fig 3.1b. Near the interface, 𝜌𝑓 should not be zero, as 𝐸 has also a large
difference at the interface between the initial two streams. The large difference in 𝐸 is due
to the difference in 𝜎, which in turn generates 𝜌𝑓 under local 𝐸. Substitution of Eq. (3) into
(6), yields:
𝜕𝑬

∇ ∙ 𝐸 ≈ − (∇𝜎 ∙ 𝐸 + 𝜀∇ ∙ 𝜕𝑡 )⁄𝜎

(7)

Substituting Eq. (7) back into Eq. (4) and (3), we find that the initial 𝐹𝑒 can be
approximately determined by:
𝐹𝒆 = −𝜀

𝛁𝜎∙𝑬
𝜎

𝐸−

𝜀2

𝜕𝑬

(∇ ∙ 𝜕𝑡 ) 𝐸
𝜎

(8)

Here the first term of Eq. (8) is consistent with the result in DC case,47 the second term is
related to the initial 𝐹𝑒 due to AC 𝐸. However, in practice, to satisfy quasi-electrostatic
condition, normally
𝜀𝑟𝑒𝑓 𝜔 < 𝜎1 < 𝜎2 − 𝜎1

(9)

where σ1 and σ2 are σ of the stream 1 and 2 respectively. Then the 2nd term of Eq. (8)
should be much smaller than the 1st term and can be neglected. We have
𝐹𝒆 = −𝜀

𝛁𝜎∙𝑬
𝜎

𝐸

(10)

Eq. (10) indicates that 𝐹𝑒 increases with increasing ∇𝜎 and 𝐸 , and parallelizing them.
Initially, at a large scale where the influence of fluid viscosity is small, 𝐹𝑒 directly drives
and causes strong chaotic EK flow. The order of the corresponding velocity can be reached
by balancing the inertial term and 𝐹𝑒 in Eq. (1) as
𝑈𝑒 = √𝜀𝑟𝑒𝑓 (𝜎2 − 𝜎1 ) 𝐸20 / 𝜌𝜎1

70

(11)

At a specific length scale l, where the time scale of convection under forcing (𝜏𝑒 = 𝑙⁄𝑈𝑒 )
is equal to the corresponding viscous diffusion time scale (𝜏𝑑 = 𝜌𝑙2 ⁄𝜇), a nominal length
scale in the EK flow can be qualitatively concluded:
𝑙𝑒𝑑 = √𝜇2 𝜎1 ⁄𝜌𝜀𝑟𝑒𝑓 𝐸20 (𝜎2 − 𝜎1 ) = √𝑤2 ⁄𝐺𝑟𝑒

(12)

𝐺𝑟𝑒 = (𝑈𝑐 𝑙 ⁄𝜈 )2 = 𝜌𝜀𝑟𝑒𝑓 𝑤 2 𝐸02 (𝜎2 − 𝜎1 )/𝜎1 𝜇 2

(13)

where 𝐺𝑟𝑒 is the nominal electric Grashof number. To describe the electrical conductivity
field in Eq (10), we need transport equation for conductivity. For a bipolar system
uniform 𝜀 , if there are neither production nor consumption of charges, the transport
equation for conductivity is: (Melcher 1981, page 5.33) 48
𝜕𝝈
𝜕𝑡

+ 𝑢 ∙ ∇𝜎 = −𝐸 ∙ ∇ [(𝑚+ − 𝑚− )𝜎 + 𝑚+ 𝑚− 𝜌𝑓 ] − [(m − 𝑚− )𝜎 + 𝑚+ 𝑚− 𝜌𝑓 ]
𝐷𝑒 ∇ 2 𝜎 +

𝑚+ 𝑚−
𝑚+ +𝑚−

𝐷𝑒 =

(𝐷+ − 𝐷− )∇2 𝜌𝑓

𝐷+ 𝑚+ +𝐷− 𝑚−

𝜌𝑓
𝜀

+

(14)

(15)

𝑚+ +𝑚−

where 𝐷𝑒 is an effective diffusivity. The concentration of the protein and polymer is
important for the nanoparticle synthesis. The protein in the solution is charged, but the
polymer is not. Ignoring the chemical reaction, the transport equation of their concentration
can be described as (Truskey et al. page 362):49
𝜕𝑐𝑖
𝜕𝑡

+ 𝑢 ∙ ∇𝑐𝑖 = 𝐷𝑚𝑖 ∇2 𝑐𝑖

𝐷𝑚𝑖 =

(𝑧+ −𝑧− )𝐷+ 𝐷−
(𝑧+ 𝐷+ −𝑧− 𝐷− )
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(16)
(17)

where 𝑐𝑖 is concentration of each component i, i.e. either polymer or protein, 𝑧− and 𝑧+ are
the charge valance of protein and ions. For polymer 𝐷𝑚𝑖 is its own diffusivity, but for
protein, 𝐷𝑚𝑖 is given in Eq. (17), where ions in buffer balance the charge of the protein.
̂⁄𝑈𝑐 𝜏 , 𝜎 = 𝜎0 𝜎̂, 𝐸 = 𝐸0 𝐸̂ , 𝑝 = 𝜌𝑈𝑐2 , 𝜀 = 𝜀𝑟𝑒𝑓 𝜀̂ ,
Let 𝑢 = 𝑈𝑐 𝑢̂, 𝑡 = 𝜏𝑡̂, 𝑥 = 𝑈𝑐 𝜏𝑥̂, ∇= ∇
𝑐 = 𝑐0 𝑐̂ , 𝜌𝑓 = 𝜀𝐸0 𝜌̂𝑓 /𝑈𝑐 𝜏, we get the dimensionless form of Eqs (1), (15) and (16) as
𝝏𝒖
̂

( 𝝏𝒕̂ + 𝑢̂ ∙ 𝛻̂ 𝑢̂ ) + 𝛻̂ 𝑝̂ +
𝜕𝜎
̂
𝜕𝑡̂

+𝑢
̂ ∙ 𝛻̂ 𝜎̂ =

𝑅𝑒,𝑚𝑖𝑔

√𝐺𝑟𝑒

̂𝝈̂ ∙𝑬̂ )
(𝜵
𝝈
̂

̂=
𝐸

𝑚 −𝑚

(𝑚++𝑚− ) (𝐸̂ ∙ 𝛻̂ 𝜎̂ + 𝜎̂ 𝜌̂𝑓 ) +
+

1

−

2

𝑆𝑐𝑒 √𝐺𝑟𝑒

𝜕𝑐̂𝑖
𝜕𝑡̂

̂ 𝜎̂ +
𝛻

𝜏𝑟 𝑅𝑒,𝑚𝑖𝑔
𝜏𝐷 √𝐺𝑟𝑒

+𝑢
̂ ∙ 𝛻̂ 𝑐̂𝑖 =

𝑚+ 𝑚−

((𝑚

+ +𝑚−

1

2

𝑆𝑐𝑚𝑖 √𝐺𝑟𝑒

𝟏

√𝑮𝒓𝒆

𝜏𝑟 𝑅𝑒,𝑚𝑖𝑔 2
𝜏𝑑 √𝐺𝑟𝑒
2

)2

̂ 𝑐̂𝑖
𝛻

) 𝛻̂ 𝜌̂𝑓

𝟐

̂ 𝑢̂
𝛻

(18)

𝑚+ 𝑚−

((𝑚

+ +𝑚−

)2

) (𝐸̂ ∙ 𝛻̂ 𝜌̂𝑓 + 𝜌̂𝑓 2 ) +
(19)

(20)

where 𝑢
̂ , 𝑥̂ , ∇̂ and 𝐸̂ , 𝜎̂ , and 𝜌̂𝑓 are dimensionless functions of 𝑢 , 𝑥 , ∇ , 𝐸 , 𝜎 and
𝜌𝑓 respectively; 𝜎0 = 𝜎2 − 𝜎1 is the initial characteristic σ of the flow; 𝐸0 = 𝑉𝑓 /√2𝑤
represents the nominal 𝐸 across the channel width 𝑤 (where Vf is the applied peak-to-peak
voltage between two electrodes. w is the width of the channel at the entrance.). 𝜀𝑟𝑒𝑓 is the
𝜀 of water at a reference T; 𝑆𝑐𝑒 = 𝜇⁄𝜌𝐷𝑒 and 𝑆𝑐𝑚𝑖 = 𝜇⁄𝜌𝐷𝑚𝑖 are Schmidt number of
effective ions and component i respectively; τr = 𝜀/𝜎0 is charge relaxation time, Re,mig =
𝑙𝐸0 (𝑚+ + 𝑚− )/𝜐 is charge migration Reynolds number, and τ𝐷 = 𝑙2 /(𝐷+ − 𝐷− ) is a
charge diffusion time respectively.
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If Gre is sufficiently high, e.g. by increasing initial(𝜎2 − 𝜎1 ), the diffusion terms
of the right side in Eq. (18), (19) and (20) become approximately negligible. Both
conductivity and concentration will be dispersed by 𝑈𝑒 and chaotic EK flow without
smearing in the entire transverse direction. This can even enhance 𝐹𝑒 and thus, mixing at
small scale to generate homogeneous ci. By increasing the initial 𝜎2 ⁄𝜎1 , 𝐸0 and
parallelizing ∇𝜎 and 𝐸, 𝐺𝑟𝑒 can be enhanced.
3.3. EXPERIMENTAL DETAILS
3.3.1. MICROCHANNEL FABRICATION
The design and fabrication of the microchannel is shown in Figure 3.2 in
supporting information. A quasi T-shaped microchannel was made of acrylic plates, gold
chips, Teflon™ PFA membrane, Teflon™ PTFE sheets and gasket by lamination-based
microfabrication.38 Gold chips were used as electrodes to make the two electrically
conductive channel sidewalls. Teflon™ PFA membranes were used to avoid the channel
clogging problems caused by the high stickiness of polymer, which has been one of the
major obstacles in microfluidic nanomaterials synthesis.50 A Teflon™ PTFE splitter plate
was used to separate the two steams initially till they meet in the microchannel and lead to
a sharp interface with high conductivity gradient between the two streams, which can
further enhance the mixing efficiency. The microchannel has a rectangular cross-section of
150 μm in width at the entrance and 230 μm in height, with the length of 5 mm. A small
divergent angle of 5° was designed to maximize the mixing efficiency (Figure 3.1b,
3.2b).38 Rubbers were used to seal the channel. Because of the rapid polymer protein co-
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assembly process under the ultrafast mixing, no significant polymer aggregates or other
clotting issues were observed during the NPs fabrication with our microfluidic channel.

Figure 3.2 Schematic of the microchannel design and fabrication (a) and the image of
microchannel near the entrance (b).
3.3.2. MATERIALS
Teflon™ PFA membrane, Teflon™ PTFE sheets were purchased from
Cshyde. Gold chips were purchased from Surepure Chemetals. Fluorescein sodium
salt, P4VP (Mw 60000), p-aminophenol (pAP, >99.0%) were purchased from
Sigma-Aldrich. Phenazine methosulfate (PMS, >98.0%) was purchased from TCI
America. NADH sodium salt was purchased from EMD Millipore. Unless otherwise
noted, all chemicals and solvents used were of analytical grade and were used as
received from commercial sources. Water (18.2 MΩ) was obtained from Milli-Q
system (Millipore). The proteins used in this work include bovine serum albumin
(BSA) (MW: 66 kDa, pI: 4.7), fluorescent protein EGFP (MW: 27 kDa, pI:5.6)
fluorescent protein mCherry (Mw: 29 kDa, pI: 5.6), N-oxygenase CmlI (Mw: 38
kDa, pI: 5.0). BSA was purchased from Sigma-Aldrich. All other proteins were
expressed in E. coli BL21 (DE3) in LB medium, and purified by nickel-nitriloacetic
acid (Ni-NTA) affinity chromatography as described previously.51,52. PBS buffer
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(NaCl 137 mM, KCl 2.7 mM, Na2HPO4 10 mM, KH2PO4 1.8 mM, pH 7.4) was used
unless otherwise noted.
3.3.3. FLOW VISUALIZATION
The microchannel was placed on an inverted fluorescent microscope
(Olympus-IX70). Solutions injection was done by a syringe pump (Harvard, Model
PHD2000 Programmable) with different flow rates. AC electric power was supplied
by a function generator (Tektronix, Model AFG3102). The visualization of the
mixing process was conducted by Epi-fluorescence imaging technique.
3.3.4. POLYMER-PROTEIN CO-ASSEMBLY
For P4VP protein(s) co-assembly with microfluidic method, P4VP dissolved
in ethanol and protein(s) dissolved in PBS were injected by two different size of
syringes (1 mL vs 10 mL). The syringe pump was used to control flow rates. AC
electric power was supplied by the function generator to provide electric field. 20
Vp-p voltage, 20 kHz frequency, 180° phase shift were used unless otherwise noted. For
P4VP-protein(s) co-assembly with conventional bulk method, 100 μL of P4VP
dissolved in ethanol was added into a glass vial containing 1mL protein(s) dissolved
in PBS buffer drop wisely during vigorous magnetic stirring. The concentration of
P4VP and proteins solution was adjusted as the same among different methods.
More than three batches of assembled samples were collected under each condition
for characterization unless otherwise noted.
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3.3.5. POLYMER-PROTEIN NPS CHARACTERIZATION
The hydrodynamic size distribution of nanoparticles was measured by
Zetasizer (Nano ZS, Malvern Instruments). The mean value for the size based on the
intensity, and the PDI, a dimensionless width parameter based on the cumulants
analysis, were reported. For TEM analysis, the NPs samples were diluted 5 times by
DI water, 20 μL diluted sample was dropped onto 250-mesh carbon-coated copper
grids. The grids were dried, washed once by DI water and observed with a Hitachi
H-8000 electron microscope. NPs size and size distribution based on TEM images
were analyzed by ImageJ software.
For protein (BSA as the model protein) loading efficiency characterization,
the NPs samples were centrifuged at 9 K rcf for 10 min at room temperature, the
supernatants were collected for a standard Bradford assay. The loading efficiency
on the NPs was calculated from the unbound proteins in the supernatant by
subtracting the amount of the unbound proteins from the initial amount of proteins
used.
For fluorescence imaging of polymer fluorescent protein(s) NPs, glass
coverslips and plates were first soaked in a 10:1 (v:v) mixture of concentrated H2SO4
and 30% H2O2 overnight, extensively rinsed with water, sonicated in absolute
ethanol for 10 mins and dried with air stream. The NPs samples after centrifuge were
dispersed on the cleaned plates covered by a coverslip and sealed by nail polish oil.
A self-assembled confocal microscope with an oil immersion, 60× NA1.4 and
PlanApo objective lens (Olympus). A continuous wave laser (477 nm, 100 µW),
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filter cubes/sets and a photomultiplier tube (PMT, HAMAMATSU, R-928) were
used.
CmlI catalyzed reactions with pAP were measured by monitoring p-nitroso
phenol (pNOP) product formation at an absorbance of 405 nm with a Molecular
Device SPECTRAMax plus 384 with a microplate reader using 0.33 cm path length.
Since CmlI enzyme is tolerant to ethanol,51 no ethanol evaporation or dialysis was
done for P4VP-CmlI NPs sample. Instead, the assembled samples were used for
activity test directly without purification. For different samples, the same amount of
free enzyme and the same percentage of ethanol (9.1%) were used.
3.3.6. CONDUCTIVITY AND VISCOSITY TEST
A conductivity meter (EXTECH ISTRUMENTS, ExStik II) was used for
conductivity test. Viscosity was tested by Cannon-Ubbelohde Viscosity meter, #25.
3.4. RESULT AND DISCUSSION
3.4.1. MIXING VISUALIZATION
To demonstrate the EK-based fast mixing process, a modified quasi T-shaped
microchannel was fabricated as shown in Figure. 3.2. Teflon materials were used to
coat the inner faces of the microchannel in order to avoid the clotting problems. Firstly,
fluorescein in PBS was mixed with deionized (DI) water using our microfluidic
system. The conductivity ratio of these two streams was 5000:1. Different flow rates
from 1 to 10 μL/min were tested (Figure 3.3). In the absence of electric field,
laminar flows were formed in the microchannel, and only some diffusion could be
observed with slower flow rate (Figure 3.3a). The boundary of the fluorescein
solution and PBS solution was blurred with 1 μL/min flow rate and became much
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clearer with higher flow rates (≥2 μL/min, Figure 3.3c, 3.3e, 3.3g). While under
electric field, chaotic flows were formed, which demonstrated dramatically
enhanced mixing (Figure 3.3b, 3.3d, 3.3f, 3.3h). Thus, significant increased
diffusion is expected. A similar phenomenon was also observed with EGFP solution
and polymer solution as injected as the two streams with ratio of ~ 6400: 1 (17260
µS/cm vs2.7 µS/cm) (Figure 3.4). Since the flow rate of EGFP solution was much larger
than that of the polymer solution, EGFP solution occupied the most space of the channel
and the boundary moved to the polymer side significantly. The boundary was still visible,
although it was less clear. In the absence of electric field, the laminar flow pattern depends
on the Peclet number (Pe), which is determined by the flow rate for certain micro flows,
and the ratio of the flow rate of the two streams.51,52 The larger the Pe, the clearer the
boundary of the two streams. For flow rates of 1 μL/min (in Figure. 3.4a) or lower, the
molecular diffusion in transverse direction becomes more important, and a less clear
interface was seen. A clearer boundary was observed when higher flow rates (≥2 μL/min)
were used as shown in Figure4c, 4e, 4g. Considering the much higher viscosity of
P4VP polymer solution than that of DI water (2.1 mm 2/s vs. 1.0 mm2/s), we can
conclude that the mixing under electric field is highly robust in this microfluidic
channel. It is worthy to note that, with a 10 μL/min flow rate, highly homogeneous
mixture of EGFP solution and P4VP solution can also be achieved at around 150
μm downstream of the entrance under electric field (Figure 4.4h), which implies a
complete mixing starting from this position.
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Figure 3.3 Visualization of mixing process with fluorescein in PBS and DI water
with different flow rate. a, c, e, g: laminar flow without electric field. b, d, f, h:
chaotic flow with electric field. The top stream is dye solution; the bottom stream is
DI water. Two 1 mL syringes were used for injection. 7 Vp-p is used. 20 Vp-p 20
kHz frequency, 180° phase shift are used. 0.015 s exposure is used during the
imaging.

Figure 3.4 Visualization of mixing process with EGFP protein in PBS and P4VP in
ethanol with different flow rates. a, c, e, g: laminar flow without electric field. b, d,
f, h: chaotic flow with electric field The top stream is EGFP solution, which is
injected by 1 mL syringe. The bottom stream is P4VP solution, which is injected by
10 mL syringe. 20 Vp-p 20 kHz frequency, 180° phase shift are used. 0.015 s
exposure is used during the imaging. The red arrows show the small fractions of
polymer solution in the channel.
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3.4.2. IMPROVED SIZE DISTRIBUTION OF POLYMER-PROTEIN NPS VIA
MICROFLUIDIC METHOD
Firstly, BSA was used as a model protein to fabricate P4VP-protein NPs in
this microfluidic method. Proteins were dissolved in PBS buffer (0.05 μg/μL), and
P4VP was dissolved in ethanol (0.5 μg/μL). Flow rates 2 μL/min, 5 μL/min and 10
μL/min were tested while the electric field condition was kept the same. Mass ratio
of P4VP to BSA was fixed as 1:1 (the volume ratio VP4VP:VBSA = 10:1).
Transmission electron microscopy (TEM) and Dynamic light scattering (DLS)
analysis shows that the size distribution of NPs produced by microfluidics is
significantly improved by comparing with the samples from conventional bulk
method (Figure 3.5). More TEM) images of NPs demonstrate further that highly
homogeneous NPs can be fabricated by microfluidic method compared to the
conventional bulk method ((Figure 3.6). Size distribution of NPs at different areas
of TEM grids was analyzed (Figure 3.6e, 3.6j, 3.6o). With higher flow rates, the
polydispersity index (PDI) of NPs is slightly increased, likely due to the reduced
mixing in the channel. On the other hand, if there was no electric field applied, much
larger and inhomogeneous NPs (average size as 680 to 770 nm depending on flow
rates) were produced, and large amount of polymer aggregates could be observed
under TEM (Figure 3.7). Within the enhanced chaotic flows, proteins and polymer
precursors can be well mixed in a very short time by increased shear stress. We
postulate that during the co-assembly in micro flows under an AC electric field, the
size of NPs and local concentration of the starting materials in the mixture can be
balanced. Thus, continuous aggregation of unassembled polymers is suppressed.
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Additionally, the residence time distribution (RTD) of the assemblies is narrowed,
which is ultimately responsible for the improved NPs’ homogeneity.

Figure 3.5 Size and size distribution of P4VP-BSA NPs fabricated by microfluidics at
different flow rates and conventional stirring method. (A-D): TEM image of nanoparticles
by microfluidics with 2 μL/min (a), 5 μL/min (b), 10 μL/min (c) and stirring method (d).
(e), (f): DLS analysis of nanoparticles by different methods. Final concertation of P4VP
0.05 mg/mL, BSA 0.05 mg/mL for all samples. Error bar stands for standard deviation of
three replicates.

Figure 3.6 Representative TEM images of P4VP-BSA nanoparticles fabricated by
microfluidics with 2 μL/min (a-d), 10 μL/min (f-i) flow rates, and bulk method (k-n). Scale
bars: 0.5 μm. (e, j, o) Statistical analysis of the NPs size and distribution. The red curves
are Gaussian fits to the corresponding histograms. For all samples, 0.05 mg/mL P4VP and
0.05 mg/mL BSA were used as final concentration.
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3.4.3 THE SIZE OF POLYMER-PROTEIN NPS IS TUNABLE
Our previous works showed that, driven by the interfacial energy, the surface
composition and materials’ concentration could influence the size of the P4VPprotein NPs.21,32 When the mass ratios of polymer to protein were adjusted as 1:8,
1:0.8 and 1:0.08 for the two streams in the microchannel, different size of NPs were
fabricated with 2 μL/min flow rate. TEM images and DLS analysis show that the
size of fabricated NPs increases with the increase of the polymer/protein mass ratio
(Figure 3.8a-d). The average hydrodynamic sizes are 284 nm, 523 nm and 925 nm
with polymer/protein ratio as 1:0.8, 1:0.08 and 1:0.008, respectively. Again, by
comparing with the NPs produced by conventional bulk method, the size
distributions of NPs fabricated through microfluidics were significantly improved
(Figure 3.8e and Figure 3.9a-d). While the NPs fabricated by microfluidic method
are stable at room temperature (Figure 3.8f), the size of NPs prepared by
conventional bulk method shows growth within 3 days’ incubation at room
temperature, especially when high polymer/protein ratio was used (Figure 3.8e), we
rationalize that it was caused by the agglomeration of polymers and NPs due to
scattered protein coating on the surface of NPs. 31,33 The sustained size and
morphology of NPs during the ethanol evaporation as well as long-term storage at 4
o

C indicate that mature and stable polymer protein NPs have been formed via

microfluidic co-assembly (Figure 3.10). The interactions between polymer and
proteins and the benign microenvironment provided by polymers likely contribute
to the stability of the enzyme and the resultant assemblies. The protein loading
efficiencies of NPs fabricated with the microfluidic method under different
conditions (with 2 μL/min to 10 μL/min flow rates and 1:1 to 1:10 polymer/protein
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mass ratios) were measured (Figure 3.11). They were around 70%, demonstrating a
good protein loading capacity using this microfluidic method. Interestingly, if the
entrance width of the channel is decreased into 90 μm, much smaller NPs can be
fabricated, nevertheless the NPs size cannot be well-controlled by adjusting
polymer/protein mass ratio anymore (Figure 3.12). We believe that the matching of
mixing time and co-assembly time is critical to control the size of final NPs. With
further increasing mixing intensity, the NPs size could be insensitive to the starting
materials ratio. Similar phenomenon has been reported for self-assembly of
copolymeric NPs.53

Figure 3.7 TEM images of P4VP-BSA nanoparticles prepared by microfluidic
method without electric field with 2 μL/min (a), 5 μL/min (b), 10 μL/min (c) flow
rate, and the DLS test (d). Final concentration as P4VP 0.05 mg/mL, BSA 0.05
mg/mL. The result is consistent with DLS test, which confirm the role of EK based
mixing contribute to the NPs’ size and size distribution. Scale bar: 1 μm.
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Figure 3.8 Different size of P4VP-BSA NPs fabricated by adjusting polymer/protein ratio
and the stability test. (a-c) Representative TEM images of P4VP-BSA with different size
fabricated by microfluidics. Scale bars represent 0.5 μm. (d) DLS analysis of different size
of NPs fabricated by microfluidics. (e) PDI comparison of the NPs fabricated by
microfluidics and conventional bulk method. **P-value < 0.01, *P-value < 0.05 by
Student’s t-test. (f) Average hydrodynamic size of NPs fabricated by microfluidics with
different aging time at room temperature as detected by DLS. A fixed concentration of 0.05
mg/mL was used for P4VP, while BSA was adjusted from 0.4 mg/mL to 0.04 mg/mL to
0.004 mg/mL for the fabrication of small, medium, and large size NPs. Error bar stands for
standard deviation of triplicate samples.

Figure 3.9 P4VP-BSA NPs prepared by conversional dropwise and stirring method and
thermostability test. The average size of NPs can be adjusted by protein/polymer ratio. (ac) Representative TEM images of P4VP-BSA with different average size. (d) DLS
measurement of the NPs with the polydispersity index as 0.20, 0.14, and 0.39, respectively.
0.05 mg/mL P4VP was used for all sample, BSA was used as 0.4 mg/mL, 0.04 mg/mL and
0.004 mg/mL for different size of nanoparticles. (e) Average hydrodynamic size of NPs
with time going at room temperature, which was detected by DLS.
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Figure 3.10 TEM images of P4VP-BSA nanoparticles prepared by microfluidics with
storing at 4 °C for 30 days (a-c) and during ethanol evaporation. Flow rate was with 2
μL/min (a), 5 μL/min (b), 10 μL/min (c-f). Final concertation of P4VP 0.05 mg/mL, BSA
0.05 mg/mL for all samples. (d) Samples without evaporation (with 10% ethanol), (e)
samples with 50% volume evaporation (with <5% ethanol left), and (f) samples with 90%
volume evaporation (with <1% ethanol left). No much difference was observed among the
samples during ethanol evaporation, which implies a stable nanostructure. Evaporation was
done at 45 °C heating block. Scale bars: 1 μm.

Figure 3.11 Loading efficiency test with P4VP-BSA NPs fabricated with different
methods: Different flow rates (2 μL/min, 5 μL/min and 10 μL/min) were tested for
microfluidic method. Final concentration of P4VP was 0.05 mg/mL for all samples. Error
bar stands for standard deviation of three replicates.
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Figure 3.12 DLS analysis of P4VP-BSA nanoparticles (a) prepared by a different
microchannel with 90 μm width at the channel entrance, and other dimensions were kept
the same (b). For all samples, 0.05 mg/mL P4VP was used, and 0.5 mg/mL and 0.05 mg/mL
BSA were used, respectively. For EK-based microfluidics control, 20 Vp-p, 20 kHz
frequency, 180° phase shift are used.
3.4.4. POLYMER-FLUORESCENT PROTEINS CO-ASSEMBLY AND FUNCTION
TEST
To characterize the structural change of NPs fabricated by microfluidic
method, EGFP and another fluorescent protein mCherry (or BSA) were used to coassemble with P4VP polymer to produce polymer multi-protein NPs P4VP-EGFPmCherry and P4VP-EGFP-BSA. Mass ratio of polymer/EGFP/mCherry (or BSA)
was fixed as 4:1:1. The BSA was used in the P4VP-EGFP-BSA to balance the
polymer protein ratio to control the NPs size. TEM imaging reveals that the
homogeneous polymer proteins NPs were fabricated successfully by microfluidic
method (Figure 3.13). Fluorescence images of P4VP-EGFP-mCherry and P4VPEGFP-BSA NPs were taken by a laser scanning confocal microscopy (Figure 3.14).
This laser is suitable to excite EGFP and minimize the ‘cross talk’ signal from
mCherry simultaneously (P4VP-mCherry-BSA NPs cannot be detected, data not
shown). Both P4VP-EGFP-mCherry and P4VP-EGFP-BSA NPs showed bright
signals in green channel. By excluding the effect of EGFP ‘leaking’ signal in red
channel and the minimal ‘cross-talk’ signal from mCherry, the red/green signal
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intensity ratio was calculated for P4VP-EGFP-mCherry and P4VP-EGFP-BSA
single NPs to show an apparent fluorescence resonance energy transfer (FRET). The
red/green signal intensity ratio of P4VP-EGFP- mCherry is much higher than that
of P4VP-EGFP-BSA (~two-fold changes, Figure 3.14g), which reveals significant
FRET occurring between the assembled EGFP and mCherry on the NPs. This result
not only demonstrates the function of both fluorescent proteins still sustained but
also implies a very closed distance between the two proteins on the NPs, which could
be potentially used for bio-imaging applications.54

Figure 3.13 TEM images of P4VP-EGFP-BSA (a), P4VP-EGFP-mCherry prepared by
microfluidic method with 10 μL/min (b) and conventional stirring method (c). Mass ratio
of P4VP: total proteins = 2:1. P4VP-CmlI NPs prepared by conventional stirring method
(d). For assembly,.0.25 mg/mL P4VP, 1.1 mg/mL CmlI were used.
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Figure 3.14 Function characterization of P4VP-protein(s) NPs prepared by microfluidic
method. Fluorescence microscopy images of P4VP-EGFP-mCherry (a-c), P4VP-EGFPBSA (d-f) show the sustained fluorescence protein(s) function on NPs and a significant
FRET effect (insets). Scale bars: 5 μm. Insets: representative image of single P4VP-EGFPBSA and P4VP-EGFP-mCherry NP; Scale bars: 500 nm. (g) Signal intensity ratio of Red
to green channels of P4VP-EGFP-mCherry and P4VP-EGFP-BSA prepared by
microfluidic method. Error bar stands for standard deviation of ten single nanoparticles of
each samples. For co-assembly, 0.05 mg/mL P4VP, 0.0125 mg/mL EGFP, 0.0125 mg/mL
mCherry or 0.0125 mg/mL BSA and 2 μL/min flow rate were used.
3.4.5. POLYMER-ENZYME CO-ASSEMBLY AND ACTIVITY TEST
To further evaluate the sustained protein function on the NPs, an Noxygenase CmlI55 was used as a model enzyme to co-assemble with P4VP polymer
by microfluidic and conventional bulk method (as reported previously). 51 TEM
image reveals highly uniform P4VP-CmlI NPs fabricated by this microfluidic
method (Figure 3.15a). It is worth to note that the homogeneity of P4VP-CmlI NPs
is slightly better than other P4VP-proteins NPs by using microfluidic method, which
could be attributed to multiple factors including protein’s MW, surface charge and
hydrophobicity and others. More systematic study will be needed to understand this
difference. CmlI enzyme activity can be determined by a p-nitrosophenol (pNOP)
based chromogenic assay with presence of p-aminophenol (pAP) as substrate,
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nicotinamide adenine dinucleotide (NADH) as electron source and phenazine
mediator (Figure 3.15a inset).51 By comparing with the activity with the same
amount of free enzyme, P4VP-CmlI NPs from either microfluidic method or bulk
method show slightly higher activity than the free enzyme (Figure 3.15b), which
can be attributed to the faster electron transferring process upon polymer assembly.51
This result confirms that CmlI enzyme function can be fully maintained after coassembly with P4VP using the microfluidic system.

Figure 3.15 (a) Representative TEM image of P4VP-CmlI NPs generated by microfluidic
method and the chromogenic reaction scheme (inset), which can be used to characterize
the polymer-enzyme NPs’ activity. Flow rate 2 μL/min was used for NPs preparation. Scale
bar: 200 nm. (b) The chromogenic reaction shows that P4VP-CmlI NPs from microfluidic
method have enzyme function fully sustained. Flow rate 10 μL/min was used for the NPs
sample production. For co-assembly in both microfluidic method and stirring method 0.25
mg/mL P4VP, 1.1 mg/mL CmlI were used. For the chromogenic activity assay 1 mM pAP,
2 mM NADH, 40 μM PMS were used.
3.5. CONCLUSION
In this work, we described an EK-based microfluidic method to fabricate functional
polymer-protein(s) NPs. The principle of fast mixing in the microchannel was illustrated
qualitatively. Experimentally, we identified the size distribution of NPs fabricated by this
microfluidic method could be significantly improved by comparing to that prepared by
conventional bulk method due to the fast mixing process. The NPs size could be controlled
by adjusting polymer/proteins ratio in the microchannel. More importantly, the
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functionality of proteins coated were sustained. Overall, this EK-based microfluidic
method displayed great advantages to fabricate functional nanoparticles, which could be
potentially used in nanoparticle preparation applications in the future.
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CHAPTER 4
USING SMALL MOLECULES TO ENHANCE OLETSA ENZYME ACTIVITY IN
SITU
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4.1 INTRODUCTION
Conversion of aliphatic carboxylic acids (e.g. fatty acids) into fuels and
platform chemicals represents a sustainable strategy in chemical industry. Despite
the success of current chemical methodologies in the decarboxylation of aliphatic
carboxylic acids,1–3 the required harsh conditions and high loadings of precious
metal catalysts imply a high environmental impact. Therefore, a biocatalytic process
at mild condition would be a viable alternative. 4,5 Although some enzymes that
utilize iron-containing cofactors to active O2 or H2O2 for the transformation of Cn
fatty aldehyde or fatty acids to Cn-1 alkenes have been reported recently,6–9 the
relatively sluggish catalytic efficiencies of the native enzymes limit their practical
applications.
Recently, increasing attentions have been given to a group of cytochrome
P450s from the CYP152 family named OleT, which catalyses the oxidative
decarboxylation of fatty acids to form terminal olefins.10–12 This single-step reaction
provides a route for drop-in fuel production from an abundant natural resource. After
the discovery of OleTJE from Jeotgalicoccus sp. 8456 by Rude and co-workers in
2011,10 collective efforts have been placed to understand this biocatalyst and the
unique decarboxylation pathways. With H2O2 as a co-factor,13 the highly reactive
and remarkably stable intermediates compound I14 and compound II15 can be
generated to achieve decarboxylation instead of the oxygen rebound producing
hydroxylated products. Therefore, H2O2 has served as a desirable attribute for
industrial transformations because of its low cost and easily scalability. On the other
hand, the H2O2 dependent decarboxylation is highly inefficient compared to most
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O2 dependent CYPs, primarily due to the potential for oxidative modification of
heme prosthetic group.16 To overcome this limitation, different strategies including
protein engineering,17 photochemistry18 and process engineering19 that generate
H2O2 in a controlled manner have been reported. Very recently, a functional ortholog
from Staphylococcus aureus, OleTSA, was characterized by Thomas Makris and
others that possesses improved features including enhanced solubility and high
stability.20,21 These features enable this ortholog to be a promising candidate for
synthesis applications.
Similar to many other P450s, OleT has been demonstrated to accommodate
a broad range of substrates including different fatty acids and non-native substrates
with a diverse size distribution and structure variation.11,22 Based on site-directed
mutagenesis studies, small alterations of the local microenvironment 23,24 can be
translated into its reactivity. Interestingly enough, the C-C bond cleavage in OleT
can be regulated by modifications of the enzyme F-G loop that is 17 Å from the
active site, reflecting a flexible substrate pocket which can impart effect on its
catalysis.20,25 In addition, cooperative binding of different compounds with other
P450 enzymes26–29 and multiple substrates binding in the enzyme active center30
have been experimentally investigated by many groups. Therefore, we envisioned
that the application of appropriate small molecules to access the OleT enzyme active
pocket may be a promising direction to leverage its catalysis efficiency.
The fatty acid binding pocket in OleT demonstrates a highly hydrophobic
feature. Particularly, hydrophobic residues including Phe46, Phe294, Phe79,
Phe173, Phe291, Phe246, Phe296, Val292, Pro246, Ile170 serve as a ‘hydrophobic
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cage’ for the fatty acid substrate in OleTJE,22,31 which are also highly conserved in
OleTSA.20 Wang and co-workers reported that only meagre or no activity
improvement was observed with the mutation of Phe to Ala near both substrate
entrance and the active site suggesting steric hindrance has minor impact during the
catalysis.22 We hypothesize that nonpolar small molecules have chances to access
the enzyme hydrophobic pocket and influence the catalysis. To test this hypothesis,
a list of small molecules was synthesized, and the OleT enzyme catalytic activity
was analysed in the presence and absence of these small molecules. Our results
showed that these molecules could enter the enzyme active center and affect the
heme spin state. Interestingly, some of these molecules could augment the enzymatic
activity of OleT. The enhanced effect of these molecules is more prominent when
high concentration of H2O2 was used to active the enzyme. And if an H2O2 gradual
releasing method was used, such as the GOx method as described in Chapter 2, the
enhanced effect of the small molecules was diminished. We therefore proposed that
the origin of the enhancement was from the enzyme oxidation step and the inhibition
of the toxic effect due to a rapid H2O2 consumption may have played a critical role
in this process.
4.2 EXPERIMENTAL SECTION
4.2.1 MATERIALS
Eicosanoic acid (C20:0), stearic acid (C18:0), palmitic acid (C16:0), myristic acid
(C14:0), lauric acid (C12:0), and capric acid (C10:0) were purchased from BDH
Chemicals. The alkene standard 1-hexadecene was purchased from TCI chemicals.
Benzene, toluene, GOx from Aspergillus niger, H2O2, hydrocinnamic acid, and 3-(4-
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bromophenyl) propionic acid were purchased from Sigma-Aldrich.

D-Glucose

was

purchased from Fisher. Unless otherwise noted, all chemicals and solvents used were of
analytical grade and were used as received from commercial sources. Unless otherwise
noted, a solution of 200 mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer.
4.2.2 OLETSA ENZYME EXPRESSION AND PURIFICATION
The protein expression and purification process is the same as that described in
Chapter 2. Briefly, the kanamycin-resistant plasmid T5 containing a OleTSA-His6 gene was
transformed BL21(DE3) containing the chloramphenicol-resistant pTF2 plasmid encoding
for GroEL/GroES/Tig chaperones. A modified Terrific Broth (TB) (24 g/L yeast extract,
12 g/L tryptone, 4 g/L peptone) supplemented with 50 μg/mL kanamycin and 20 μg/mL
chloramphenicol was used for culturing. For protein expression, 125 mg/L thiamine, and
trace metals, 100 μM IPTG, 10 ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid
were added. The expression was done at 18 °C for 16-18 h. The protein was purified using
nickel-nitriloacetic acid (Ni-NTA) affinity chromatography followed by Butyl-SSepharose column polishing step as described previously. Fractions with an Rz value
(Abs418 nm/Abs280 nm) above 1.2 were pooled and dialyzed against buffer A. Proteins
were stored at -80 °C until further use.
4.2.3 GENERAL PROCEDURE TO PREPARE DIFFERENT MOLECULES
4.2.3.1 PREPARATION OF 1-PHENYL-1H-1,2,3-TRIAZOLE (MOLECULE 3)

Scheme 4.1 Synthesis of molecule 3.

99

In an oven dried Schlenk tube, azidobenzene (1 mmol), 2-methylbut-3-yn-2-ol (1
mmol), CuI (5 mol%), Sodium ascorbate (10 mol%) and KOH (5 mmol) were mixed in
toluene and methanol (v/v =1:3, 8 mL) stirred at 130 °C for 2 days under argon. The
mixture was cooled down to room temperature and purified by flash chromatography
(hexane/ethylacetate = 10:1-3:1) to afford the corresponding product of yield 70 %.32
4.2.3.2 PREPARATION OF 4-MONOSUBSTITUTED
TRIAZOLE (MOLECULE 4 AND 7)

1-PHENYL-1H-1,2,3-

Scheme 4.2 Synthesis of molecule 4 and 7
Azidobenzene (1 mmol) and terminal alkene (1 mmol) were mixed in water and
ethanol (v/v =1:1, 14 mL). Sodium ascorbate (10 mol%) of freshly prepared 1 M solution
in water was added, followed by the addition of CuSO4·5H2O (5 mol%) in water. The
mixture was stirred overnight at room temperature. The solvent was completely removed
and purified by column using hexane/ethyl acetate= 10:1-2:1, or DCM/methanol = 100:150:1, as the eluent to afford the corresponding product. The average yields are 80-85 %.
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4.2.3.3 PREPARATION
(MOLECULE 5)

OF

N-SUBSTITUTED

BENZENE

SULFONAMIDE

Scheme 4.3 Synthesis of molecule 5.
To a solution of N-butylamine or N-ethylamine (4 mmol) in dry DCM (10 mL),
triethylamine (6 mmol) was added followed by a solution of benzenesulfonyl chloride (4
mmol) in dry DCM (10 mL) in an ice bath. The reaction mixture was stirred overnight at
room temperature. The DCM was evaporated under reduced pressure, H2O (10 mL) was
added, and the pH was adjusted to 2 with 1 N HCl. The product was extracted with DCM
(3×10 mL), and the combined organic layers were concentrated under reduced pressure.
The rude product was purified by column using Hexane/Ethyl acetate = 20:1-10:1 as eluent
to afford the target product. The average yields were 85-88 %.
4.2.4 SMALL MOLECULES CHARACTERIZATION
The 1H and 13C NMR spectra were recorded at 298 K in deuterated solvents using
Bruker Advance 400 MHz spectrometer. Data are represented as below: chemical shift,
multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), coupling constants in Hertz
(Hz), integration.
1-phenyl-1H-1,2,3-trizaole (Molecule 3)
White solid. 1H NMR (400 MHz, CDCl3): δ 8.00 (d, J = 0.1 Hz, 1 H), 7.84 (s, 1 H), 7.757.72 (m, 2 H), 7.54-7.49 (m, 2 H), 7.46-7.41 (m, 1 H).

13

C NMR (100 MHz, CDCl3): δ

137.1, 134.6, 129.9, 128.9, 121.8, 120.8. HRMS: [M + H]+ m/z calcd for C8H7N3H+:
146.0713, found: 146.0713.
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Figure 4.1 1H NMR spectrum of Molecule 3

Figure 4.2 13C NMR spectrum of Molecule 3
4-bultyl-1-phenyl-1H-1,2,3-triazole (Molecule 4)
Yellow solid. 1H NMR (400 MHz, CDCl3): δ 7.71 (s, 1 H), 7.68 (d, J = 7.9 Hz, 2 H), 7.46
(d, J = 7.7 Hz, 2 H), 7.39-7.33 (m, 1 H), 2.76 (d, J = 7.7 Hz, 2 H), 1.74-1.64 (m, 2 H), 1.46-
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1.33 (m, 2 H), 0.92 (t, J = 7.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ 149.2, 137.3, 129.7,
128.4, 120.3, 118.9, 31.5, 25.4, 22.3, 13.9. HRMS: [M + H]+ m/z calcd for C12H15N3H+:
202.1339, found: 202.1339

Figure 4.3 1H NMR spectrum of Molecule 4
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Figure 4.4 13C NMR spectrum of Molecule 4
N-butylbenzenesulfonamide (Molecule 5)
Yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.89-7.88 (m, 1 H), 7.87-7.86 (m, 1 H), 7.597.55 (m, 1 H), 7.52-7.48 (m, 2 H), 4.87 (s, 1H), 2.96-2.90 (m, 2 H), 1.46-1.39 (m, 2 H),
1.31-1.22 (m, 2 H), 0.82 (t, J = 3.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ 140.0, 132.7,
129.2, 127.1, 43.0, 31.6, 19.8, 13.6. HRMS: [M + H]+ m/z calcd for C10H15NO2SH+:
214.0896, found: 214.0896.
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Figure 4.5 1H NMR spectrum of Molecule 5

Figure 4.6 13C NMR spectrum of compound Molecule 5
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N-ethylbenzenesulfonamide (Molecule 6)
Yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.89-7.88 (m, 1 H), 7.87-7.86 (m, 1 H), 7.607.56 (m, 1 H), 7.54-7.49 (m, 2 H), 4.57 (s, 1 H), 3.05-2.98 (m, 2 H), 1.10 (t, J = 7.2 Hz, 3
H). 13C NMR (100 MHz, CDCl3): δ 140.0, 132.7, 129.2, 127.2, 38.4, 15.2. HRMS: [M +
H]+ m/z calcd for C8H11NO2SH+: 186.0583, found: 186.0583.

Figure 4.7 1H NMR spectrum of Molecule 6
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Figure 4.8 13C NMR spectrum of Molecule 6
(1-phenyl-1H-1,2,3-triazole-4-yl)methanol (Molecule 7)
Yellow oil. 1H NMR (400 MHz, DMSO-d6): δ 8.69 (s, 1 H), 7.92-7.90 (m, 2 H), 7.62-7.58
(m, 2 H), 7.50-7.46 (m, 1 H), 5.36 (t, J = 5.6 Hz, 1 H), 4.62 (d, J = 5.7 Hz, 2 H). 13C NMR
(100 MHz, DMSO-d6): δ 149.7, 137.2, 130.3, 128.9, 121.5, 120.4, 55.4. HRMS: [M + H]+
m/z calcd for C9H9N3OH+: 176.0818, found: 176.0818.
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Figure 4.9 1H NMR spectrum of Molecule 7

Figure 4.10 13C NMR spectrum of Molecule 7
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4.2.5 UV-VIS SPECTRUM ANALYSIS
UV-Visible spectroscopy was detected on an HP 8453 spectrophotometer. A quartz
cuvette with 1 cm path length was used. Different OleTSA enzyme in buffer A in the
absence and presence of small molecules was analyzed.
4.2.6 OLETSA ENZYME ACTIVITY ASSAY
Eicosanoic acid and stearic acid stock (10 mM) were dissolved in 70% ethanol/30%
Triton X-100 (v:v, unless otherwise noted) as stocks. Other fatty acids including palmitic
acid, myristic acid and lauric acid were dissolved in DMSO to make 10 mM stocks.
Hydrocinnamic acid and 3-(4-bromophenyl) propionic acid was dissolved in DMSO to
make a 400 mM stock. To set up enzymatic reactions, OleTSA enzyme, substrate and small
molecule diluted into desired concentration from stocks in buffer for multiple-turnover
reactions in a 150 μL volume. Small molecules were omitted for control reactions. 2 mM
of H2O2 was added to initiate the reactions in H2O2 method. 300 nM of GOx was used in
GOx method, and 6.6 mM of D-glucose was added to initiate the reactions unless otherwise
noted. The steady-state reactions were quenched with 0.4 mM HCl or 1% acetic acid for
GC/GC-MS or LC/LC-MS analysis, respectively.
4.3 RESULT AND DISCUSSION
4.3.1 SMALL MOLECULES PROFILE EXPLORED ON OLETSA CATALYSIS
Initially benzene (1) and toluene (2) were added to the reaction of
hydrocinnamic acid catalysed with OleTSA. As shown in Table 4.1, an enhancement
of 14% and 20% were observed respectively in the presence of 1 mM of benzene
and toluene. This result promoted us to further synthesize a series of small molecules
(3-7). OleT metabolized hydrocinnamic acid reactions with and without these small
molecules were analyzed by HPLC (Table 4.1).

109

Table 4.1 The small molecules’ effect on OleTSA activity
Molecule

Structure

OleT activitya
enhancement (%)

1

14 ± 2

2

20 ± 3

3

79 ± 11

4

209 ± 23b

5

101 ± 18b

6

63 ± 5

7

-6 ± 1

Reaction condition: 5 μM OleTSA, 2 mM H2O2, 2 mM hydrocinnamic acid,
incubation at RT for 30 min with and without 1 mM small molecules.
b
Because OleT can further metabolize styrene into styrene oxide, which was not
characterized in this work, the observed enhancement at 30 min reactions is lower
than that at 10 min reactions (see Figure 4.12).
a

4.3.2 UV-VIS SPECTROSCOPIC ANALYSIS
It has been well established that UV-Vis spectra of cytochrome P450s is
sensitive to the redox state of the heme as well as its local environment.33 OleT is in
a low-spin ferric resting state with its heme iron axially coordinated by cysteine
thiolate and a distal H2O molecule, which shows a maximum Soret band at 418 nm.
Substrate binding displaces the axial water and converts the heme iron from lowspin to a high-spin state with a maximum Soret band at 394 nm (Figure 4.11).16
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Therefore, we can readily use UV-Vis spectroscopy to evaluate the interaction of
small molecules with the OleT active site. As shown in Figure 4.12B, with addition
of 2.5 mM of 3 to OleTSA (at the low-spin state), a shift of heme spectrum was
observed, indicating a close proximity of 3 to the heme. Similar phenomenon was
observed for the as-purified OleTSA treating with 3 (Figure 4.12C), while 3 has no
specific absorbance above 300 nm wavelength (Figure 4.12D). These spectrum
shifts suggest an interfering effect between heme and H2O/substrates. With addition
of eicosanoic acid (C20 FA) followed by 3, the enzyme shifted from low-spin state
to high-spin state, clearly demonstrating that the presence of 3 does not hinder the
C20 FA binding to the enzyme active site.

Figure 4.11 Scheme of the OleTSA catalytic cycle. OleTSA is in a ferric resting state
with its heme iron coordinated by a H2O molecule. (i). Substrate binding displaces
the axial water and converts the heme iron from low-spin to a high-spin state. (ii).
H2O2 reacts with the high-spin enzyme to yield the reactive ferryl (FeIV)-oxo
porphyrin radical cation (Cpd I, iii). Cpd I abstracts a hydrogen atom from the Cβ
position, resulting in formation of a substrate radical and the ferryl (FeIV)-hydroxo
species (Cpd II, iv), from which Cα–Cβ double bond forms, a CO2 eliminates and a
terminal alkene releases. The simultaneous recruitment of a proton to the heme
restores the resting state(i).
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Figure 4.12 (A) Scheme of OleTSA catalyzed decarboxylation reactions with
activator (top) and fatty acids coordinating to the active center with small molecule
accessing (bottom). (B) UV-Vis spectrum of low-spin state of OleTSA (5 μM)
binding with 3 (2.5 mM) and eicosanoic acid (5 μM). (C) UV-Vis spectrum of
OleTSA as purified treated by 3 (5 mM) and (D) 3 only (5 mM).
4.3.3 OLETSA ACTIVITY ANALYSIS IN THE PRESENCE OF SMALL MOLECULES
To test the effect of 3 on OleTSA enzymatic activity, OleT catalyzed C20 FA
reactions was done in the presence of different concentration of 3. Nonadecene, as
the sole product of the reaction, was monitored. As shown in Figure 4.13A, with
increasing concentration of 3 from 1 mM to 20 mM added, increasing production of
nonadecene was obtained, indicating that 3 acted as an OleTSA enzyme activator in
these reactions. Neither saturation nor inhibiting effect was observed, which implies
that the small molecules do not hinder the C20 FA binding to the enzyme. A typical
time course analysis of the reaction with C20 FA as substrate was shown in Figure
4.13B. Interestingly, a burst of product release was observed at 5 min of reaction,
and more than 2.5-fold nonadecene yield was obtained in the presence of 3. A similar
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enhanced OleT activity was observed with stearic acid (C18 FA) and hydrocinnamic
acid as substrates (Figure 4.13C, Figure 4.14). When the chain length of fatty acid
got shorter, the enhancement of catalytic efficiency became less significant (e.g.
49% of enhancement for palmitic acid (C16 FA) vs. 31% of enhancement for
myristic acid (C14 FA) vs. < 7% of enhancement for lauric acid (C12 FA) (Figure
4.13C, Figure 4.14). We believe that the varied conformation of the different chain
length of fatty acids in the hydrophobic enzyme pocket may restrict the small
molecule’s effect. Above data support our hypothesis that the small molecules get
access to enzyme pocket and accelerate the catalysis by modifying heme local
environment (Figure 4.11A).

Figure 4.13 (A) OleTSA activity test in the presence of different concentration of 3.
Reaction condition: 5 μM OleTSA, 1 mM C20 FA, 2 mM H2O2, 60 min at room
temperature. (B) Time course study of nonadecene production in the presence or
absence of 3. Reactions were performed with 1 mM C20 FA, 2 mM H 2O2, with 20
mM 3 or without 3 (as control). (C) Up to 3.5-fold enhanced OleT activity in the
presence of 3 can be achieved depending on different substrates including C20 FA,
C18 FA, C16 FA, C14 FA, C12 FA and hydrocinnamic acid (HA). Only
corresponding terminal alkene production was recorded here. Reaction condition: 5
μM OleTSA, 1 mM substrates. 2 mM H2O2. Note: C20 fatty acid was dissolved in
70% ethanol/30% triton, all other substrate stocks were dissolved in DMSO. For the
reactions with C20, C18, C16, C14 FA substrates, 20 mM small molecule was used;
for reactions with C12 FA and HA substrate, 2 mM small molecule was used. Error
bars indicate the standard deviation of duplicate experiments (n = 2).
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Figure 4.14 Molecule 3 concentration dependence tests of OleTSA catalysis with
C18 FA (A), C16 FA (B), C14 FA (C) and C12 FA (D). Corresponding alkene
production was reported. Reaction condition: OleTSA 5 μM, fatty acid 0.5 mM, and
2 mM H2O2, 150 μL reaction incubation RT for 60 minutes. 250 μM C16 alkene was
used as internal standard. 300 μL CHCl3 extraction before GC. Error bars indicate
the standard deviation of duplicate experiments (n = 2).
While 3 displays significantly activating effect on OleT catalysis, a high
working concentration is required. One possible reason for this limitation is because
of its low potency to pass through the enzyme channel. To overcome this limitation,
by mimicking the fatty acid structure, 4 was synthesized with a four-carbon ‘tail’
attached to the triazole group (Table 1, 4). We hypothesize that this molecule is
easier to get into OleT enzyme active site, thus it can facilitate the catalysis by
coordinating the heme structure and substrates. To avoid the potential blocking
effect on fatty acids substrates due to the carbon tail of 4, hydrocinnamic acid (HA)
and bromophenyl propionic acid (BA) were used as substrates to identify the effect
of 4 on the enzyme activity. As shown in Figure 4.15A, in the presence of 1 mM of
4, OleTSA displayed significant improved catalytic efficiency (5.5-fold enhancement
for HA, 1.5-fold enhancement for BA relative to that in the absence of such small
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molecules). Since HA binding does not introduce spin shift of OleT significantly,
we used BA as a model to illustrate the binding spectra of OleTSA with 4. As shown
in Figure 4.15B, by treating with 50 μM BA, the enzyme showed a significant lowspin to high-spin switch. With the addition of 4 (the concentration increased from
50 μM to 200 μM) followed by BA, further extent of spin shifts of OleTSA occurred
demonstrating a cooperative-like binding of small molecule and substrate with OleT
active site. Furthermore, in the presence of 2 mM 4, around 1-fold of decreased KD
was obtained compared to that in the absence of small molecule (Figure 4.15C, D).
Unexpectedly, we found that 4 could be hydroxylated by OleTSA with a slow
reaction rate (Figure 4.16). Overall, these results confirm our hypothesis that the
selected small molecules and substrates locate to the enzyme active site
simultaneously as shown in Figure 4.11A. C20 FA metabolism was also tested in
the presence of 4, no notable enhanced OleT activity was observed, which may be
attributed to the blocking effect of these small molecules to the large fatty acids. or
a different conformation of the more complicated van der Waals complex. Further
investigation of the enzyme/small molecules complex structure will be helpful to
understand the reasons.
Another set of molecules including 5, 6, 7 (Table 4.1) were synthesized to
further explore the potential OleT enzyme activators with HA as substrate. 5 can
also serve as a potent OleT activator (e.g. > 100% enhancement of OleT activity on
hydrocinnamic acid). While with a short ‘hydrophobic tail’ in 6, the enhanced effect
was significant decreased. With one hydroxyl group added in the end of the tail of
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7, the enhanced effect on the enzyme was totally abolished implying the importance
of the nonpolar tails.

Figure 4.15 (A) Molecule 4 increases OleT activity on hydrocinnamic acid (HA) and
bromophenyl propionic acid (BA) as substrates. OleTSA (5 μM), 4 (1 mM), substrate (1
mM), and H2O2 (2 mM) were incubated at room temperature for 10 min. The reactions
without 4 were carried out as controls. Error bars indicate the standard deviation of
duplicate experiments (n = 2). (B) BA (50 μM) and 4 demonstrate cooperativity in binding
spectra. (C) UV-Vis binding titration of BA with OleT and the dissociation constant
calculation. (D) UV-Vis binding titration of BA with OleT in the presence of 4 (200 μM)
and the dissociation constant calculation.
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Figure 4.16 (A) LC spectrum of metabolized 3 by OleTSA. Reaction condition: 0.5 mM 4,
5 μM OleTSA, 2 mM H2O2, incubation at room temperature for 30 min. 1,2,3,4-tetrametyl
benzene was used as standard. (B) Hydroxylated product was identified by mass
spectrometry analysis (Top). The mass spectrometry analysis of Molecule 3 is shown
(Bottom) Further characterization of the product is undergoing in our lab.
4.3.4 THE ORIGINS OF THE OLETSA ACTIVITY ENHANCEMENT ANALYSIS
The shift of heme spectrum of low-spin state enzyme (Figure 4.12B) caused by the
small molecules suggesting that these small molecules could alter the heme/H2O local
environment, from which the enzyme could be readily oxidized by H2O2 for its catalysis
(Figure 4.1). It is possible that the reactivity between heme and H2O2 is altered by the small
molecule, which facilitates the enzyme’s catalysis. The improved efficiency in this step
further releases the oxidative stress caused by excess of H2O2. Both effects could contribute
to the apparent enzymatic activity. To identify this possibility, a H2O2 titration assay was
done in the presence and absence of 3. As shown in Figure 4.17A, the optimal
concentration of H2O2 for OleTSA activity was 2 mM. With increasing concentration of
H2O2, OleTSA showed decreased activity because of the oxidative toxicity of H2O2. Clearly
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the enhanced effect of the small molecule was highly related to the H2O2 concentration.
For example, when 0.2 mM H2O2 was used, only around 20% enhancement was obtained
in the presence of 2 mM of 3. With increasing H2O2concentration up to 30 mM, 6 to 50fold enhancement was observed. It suggests that the toxicity of H2O2 to OleTSA enzyme
can be dramatically inhibited by small molecules indicating an oxidative stress releasing
involved mechanism. In Chapter 2, we utilized GOx and glucose to develop an in situ H2O2
generating method to optimize the OleT catalytic efficiency by minimizing H2O2 toxicity.
With this method, the small molecule dependent enhancement on the enzyme catalytic
efficiency was diminished (Figure 4.17B) further supporting our hypothesis that the origin
of the enhancement of small molecules is from enzyme oxidative step.

Figure 4.17 (A) Molecule 3 stimulates OleT enzymatic activity in the presence of high
H2O2 concentration. Reactions were performed with 5 μM OleTSA, 2 mM 3, 2 mM HA and
different concentration of H2O2 for 1h reaction at room temperature. (B) The enhanced
effect of 3 on OleT catalytic efficiency is diminished with an H2O2 in-situ release process
(GOx method). One-time addition of H2O2 (2 mM) was used in H2O2 method. GOx (300
nM) and glucose (6.6 mM) were used in GOx method. In all conditions, 5 μM OleTSA, 1
mM HA, 1-hour reaction at room temperature were used in all conditions. Error bars
indicate the standard deviation of duplicate experiments (n = 2).
4.4 CONCLUSION
In summary, we report to use small molecules to leverage P450 OleTSA
enzymatic catalysis. Though only a small scale of molecules explored in this work,
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up to 6-fold enhanced OleT enzymatic activity have been obtained. We found that
the small molecules and enzyme substrates could reside in the enzyme active site
simultaneously, and proposed the origins of the enhancement were from the enzyme
oxidation step and an H2O2 toxicity inhibiting effect. Our work sheds the light to the
application of small molecules to increase OleT catalytic efficiency, which could be
potentially used for future olefin-production applications. However, further
mechanistic investigation, especially on the enzyme-small molecule-substrate
complex structure data, is necessary to better understand the system. It may also
provide direct evidence and useful information for the design of next generation
activators.
4.5 REFERENCES
(1)
Aransiola, E. F.; Ojumu, T. V.; Oyekola, O. O.; Madzimbamuto, T. F.; IkhuOmoregbe, D. I. O. A Review of Current Technology for Biodiesel Production: State of
the Art. Biomass Bioenergy 2014, 61, 276–297.
(2)
Das, S.; Join, B.; Junge, K.; Beller, M. A General and Selective Copper-Catalyzed
Reduction of Secondary Amides. Chem. Commun. 2012, 48 (21), 2683–2685.
(3)
Das, S.; Möller, K.; Junge, K.; Beller, M. Zinc-Catalyzed Chemoselective
Reduction of Esters to Alcohols. Chem. Eur. J. 2011, 17 (27), 7414–7417.
(4)
Robles-Medina, A.; González-Moreno, P. A.; Esteban-Cerdán, L.; Molina-Grima,
E. Biocatalysis: Towards Ever Greener Biodiesel Production. Biotechnol. Adv. 2009, 27
(4), 398–408.
(5)
Dennig, A.; Kurakin, S.; Kuhn, M.; Dordic, A.; Hall, M.; Faber, K. Enzymatic
Oxidative Tandem Decarboxylation of Dioic Acids to Terminal Dienes. Eur J Org Chem
2016, 2016 (21), 3473–3477.
(6)
Qiu, Y.; Tittiger, C.; Wicker-Thomas, C.; Le Goff, G.; Young, S.; Wajnberg, E.;
Fricaux, T.; Taquet, N.; Blomquist, G. J.; Feyereisen, R. An Insect-Specific P450 Oxidative
Decarbonylase for Cuticular Hydrocarbon Biosynthesis. Proc. Natl. Acad. Sci. U.S.A.
2012, 109 (37), 14858–14863.

119

(7)
Schirmer, A.; Rude, M. A.; Li, X.; Popova, E.; Cardayre, S. B. del. Microbial
Biosynthesis of Alkanes. Science 2010, 329 (5991), 559–562.
(8)
Rui, Z.; Harris, N. C.; Zhu, X.; Huang, W.; Zhang, W. Discovery of a Family of
Desaturase-Like Enzymes for 1-Alkene Biosynthesis. ACS Catal. 2015, 5 (12), 7091–
7094.
(9)
Kallio, P.; Pásztor, A.; Thiel, K.; Akhtar, M. K.; Jones, P. R. An Engineered
Pathway for the Biosynthesis of Renewable Propane. Nat Commun 2014, 5, 1–8.
(10) Rude, M. A.; Baron, T. S.; Brubaker, S.; Alibhai, M.; Cardayre, S. B. D.; Schirmer,
A. Terminal Olefin (1-Alkene) Biosynthesis by a Novel P450 Fatty Acid Decarboxylase
from Jeotgalicoccus Species. Appl. Environ. Microbiol. 2011, 77 (5), 1718–1727.
(11) Lu, C.; Shen, F.; Wang, S.; Wang, Y.; Liu, J.; Bai, W.-J.; Wang, X. An Engineered
Self-Sufficient Biocatalyst Enables Scalable Production of Linear α-Olefins from
Carboxylic Acids. ACS Catal. 2018, 8 (7), 5794–5798.
(12) Dennig, A.; Kuhn, M.; Tassoti, S.; Thiessenhusen, A.; Gilch, S.; Bülter, T.; Haas,
T.; Hall, M.; Faber, K. Oxidative Decarboxylation of Short-Chain Fatty Acids to 1Alkenes. Angew Chem Int Ed 2015, 54 (30), 8819–8822.
(13) Wise, C. E.; Hsieh, C. H.; Poplin, N. L.; Makris, T. M. Dioxygen Activation by the
Biofuel-Generating Cytochrome P450 OleT. ACS Catal. 2018, 9342–9352.
(14) Grant, J. L.; Hsieh, C. H.; Makris, T. M. Decarboxylation of Fatty Acids to
Terminal Alkenes by Cytochrome P450 Compound I. J. Am. Chem. Soc. 2015, 137 (15),
4940–4943.
(15) Grant, J. L.; Mitchell, M. E.; Makris, T. M. Catalytic Strategy for Carbon−carbon
Bond Scission by the Cytochrome P450 OleT. PNAS 2016, 113 (36), 10049–10054.
(16) Munro, A. W.; McLean, K. J.; Grant, J. L.; Makris, T. M. Structure and Function
of the Cytochrome P450 Peroxygenase Enzymes. Biochem. Soc. Trans. 2018, 46 (1), 183–
196.
(17) Matthews, S.; Tee, K. L.; Rattray, N. J.; McLean, K. J.; Leys, D.; Parker, D. A.;
Blankley, R. T.; Munro, A. W. Production of Alkenes and Novel Secondary Products by
P450 OleTJE Using Novel H2O2-Generating Fusion Protein Systems. FEBS Lett. 2017,
591 (5), 737–750.
(18) Zachos, I.; Gaßmeyer, S. K.; Bauer, D.; Sieber, V.; Hollmann, F.; Kourist, R.
Photobiocatalytic Decarboxylation for Olefin Synthesis. Chem. Commun. 2015, 51 (10),
1918–1921.

120

(19) Amaya, J. A.; Rutland, C. D.; Makris, T. M. Mixed Regiospecificity Compromises
Alkene Synthesis by a Cytochrome P450 Peroxygenase from Methylobacterium Populi. J.
Inorg. Biochem. 2016, 158, 11–16.
(20) Amaya, J. Mechanisms of Decarboxylation in The CYP152 Family of Cytochrome
P450S. Theses and Dissertations 2018.
(21) Jiang, Y.; Li, Z.; Wang, C.; Zhou, Y. J.; Xu, H.; Li, S. Biochemical Characterization
of Three New α-Olefin-Producing P450 Fatty Acid Decarboxylases with a Halophilic
Property. Biotechnol. Biofuels 2019, 12 (1), 79.
(22) Wang, J.; Lonsdale, R.; Reetz, M. T. Exploring Substrate Scope and
Stereoselectivity of P450 Peroxygenase OleTJE in Olefin-Forming Oxidative
Decarboxylation. Chem. Commun. 2016, 52 (52), 8131–8133.
(23) Hsieh, C. H.; Makris, T. M. Expanding the Substrate Scope and Reactivity of
Cytochrome P450 OleT. Biochem. Biophys. Res. Commun 2016, 476 (4), 462–466.
(24) Matthews, S.; Belcher, J. D.; Tee, K. L.; Girvan, H. M.; McLean, K. J.; Rigby, S.
E. J.; Levy, C. W.; Leys, D.; Parker, D. A.; Blankley, R. T.; et al. Catalytic Determinants
of Alkene Production by the Cytochrome P450 Peroxygenase OleTJE. J. Biol. Chem. 2017,
292 (12), 5128–5143.
(25) Amaya, J. A.; Rutland, C. D.; Leschinsky, N.; Makris, T. M. A Distal Loop
Controls Product Release and Chemo- and Regioselectivity in Cytochrome P450
Decarboxylases. Biochemistry 2018, 57 (3), 344–353.
(26) Hummel, M. A.; Gannett, P. M.; Aguilar, J. S.; Tracy, T. S. Effector-Mediated
Alteration of Substrate Orientation in Cytochrome P450 2C9. Biochemistry 2004, 43 (22),
7207–7214.
(27) Cameron, M. D.; Wen, B.; Roberts, A. G.; Atkins, W. M.; Patricia Campbell, A.;
Nelson, S. D. Cooperative Binding of Acetaminophen and Caffeine within the P450 3A4
Active Site. Chem. Res. Toxicol. 2007, 20 (10), 1434–1441.
(28) Mast, N.; Verwilst, P.; Wilkey, C. J.; Guengerich, F. P.; Pikuleva, I. A. In Vitro
Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds. J.
Med. Chem. 2019. doi.org/10.1021/acs.jmedchem.9b01383.
(29) Shoji, O.; Aiba, Y.; Watanabe, Y. Hoodwinking Cytochrome P450BM3 into
Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition. Acc.
Chem. Res. 2019, 52 (4), 925–934.

121

(30) Wang, M.; Baaden, M.; Wang, J.; Liang, Z. A Cooperative Mechanism of
Clotrimazoles in P450 Revealed by the Dissociation Picture of Clotrimazole from P450. J.
Chem. Inf. Model. 2014, 54 (4), 1218–1225.
(31) Hsieh, C. H.; Huang, X.; Amaya, J. A.; Rutland, C. D.; Keys, C. L.; Groves, J. T.;
Austin, R. N.; Makris, T. M. The Enigmatic P450 Decarboxylase OleT Is Capable of, but
Evolved To Frustrate, Oxygen Rebound Chemistry. Biochemistry 2017, 56 (26), 3347–
3357.
(32) Liu, Y.; Han, C.; Ma, X.; Yang, J.; Feng, X.; Jiang, Y. One-Pot Synthesis of 1Monosubstituted-1, 2, 3-Triazoles from 2-Methyl-3-Butyn-2-Ol. Tetrahedron Letters
2018, 59 (7), 650–653.
(33) Luthra, A.; Denisov, I. G.; Sligar, S. G. Spectroscopic Features of Cytochrome
P450 Reaction Intermediates. Arch Biochem Biophys 2011, 507 (1), 26–35.

122

CHAPTER 5
BIPHASIC CATALYSIS USING SURFACTANT ASSISTED ENZYME BASED
INTERFACIAL ASSEMBLY FOR TERMINAL ALKENE PRODUCTION
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5.1 INTRODUCTION
Organic-aqueous biphasic catalysis is an important process in chemical industry
because it provides a way of heterogenizing the catalysts and substrates/products into two
immiscible phases, which are ready for separation and purification.1,2 This process is
particularly useful for enzyme based synthesis because enzymes prefer aqueous media like
that in natural environment, while many substrates/products (e.g. lipids, fatty acids,
alkenes) have limited solubility in water.3 The organic-aqueous biphasic catalysis represent
a promising strategy to address these limitations. The slow mass transportation due to the
small interfacial areas in the biphasic reactions will, however, significantly reduce the
enzymatic reaction rates. A versatile method to address this problem is to create an
emulsion (i.e. classical emulsion, Pickering emulsion) with aqueous phase containing
catalysts and organic phase containing the substrates and /or products.
A classical emulsion (as shown in Figure 5.1A) is to introduce surfactants or
surface-active polymers (i.e. polymers with amphiphilic properties) to stabilize dispersions
in aqueous or non-aqueous media.4 The hydrophile-lipophile balance (HLB) number, the
packing parameter setting by geometry of the surfactant molecules, and the extent of
hydration/solvation by separated phase are important variables in determining whether
aggregated surfactant (micelles or emulsion droplets) resides in either water, oil, or a third
phase.5 With selected surfactants and well-designed polymers, some examples of
enzymatic reactions conducted in emulsions or reverse micelles as ‘nanoreactor’ have been
reported.6–9 The increased interfacial area of different phases and improved stability of
enzymes encapsulated in the emulsion droplets were attributed to the advanced catalytic
efficiency.
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Solid nano- or microparticles can function in similar ways as surfactants to form
emulsions, which was firstly reported by Picking and Ramsden10 about a century ago and
thus known as Pickering emulsions (Figure 5.1B). One key relevant parameter determining
Pickering emulsion type is the contact angle (θ), which the particle makes with the interface
determined by the partial wettability of the solid by different phases.5,11,12 Pickering
emulsion does not require surfactants that often show adverse effects on enzymes’
functionality (for example through irritancy, hemolytic behavior), but retains the basic
properties of classical emulsions. Pickering emulsions are usually much smaller than
classical emulsions depending on the size of solid particles. Recently, increasing attentions
have been given to use Pickering emulsion for enzymatic biphasic catalysis,13–16 which
demonstrated superior catalytic efficiency compared to conventional biphasic reactions.
Besides solid particles, we and others have established that bionanoparticles such as plant
viruses, bacterial phages and ferritins can also be used for Pickering emulsions to generate
droplets or nanoparticles through interfacial assembly.11,17,18

Figure 5.1 Schematic illustration of classical (surfactant-based) emulsion (A) and a
Pickering emulsion (B). Both represent oil-in-water type.
Many proteins are surface-active molecules because of their amphiphilic nature
which makes them a logic choice as emulsifiers/stabilizers of emulsions. In particular,
some milk proteins (e.g. β-lactoglobulin and β-casein) have been widely used in food
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emulsions.19 However, due to a dramatic change of the polarity in environment, many
proteins could lose part of their tertiary structural features upon adsorption to the oil/water
interface and generate considerable amounts of non-native secondary structures.20 Except
of some special interface-activating enzymes (e.g. lipase),21 it is a challenge to employ
functional proteins (e.g. enzymes) directly as the ‘emulsifier’ for emulsion formation. In
our previous study, we utilized co-assembly strategy to generate polymer-protein core shell
nanoparticles, in which enzymes, playing a surfactant-like role, adsorbed on the polymeric
surface and stabilized the nanosturcutre.22,23 Some efforts have been placed to utilize the
polymers to modulate enzymes’ surface properties in order to facilitate emulsions forming
and maintain enzymes’ function in a harsh environment.15,24,25
P450 OleTSA enzyme26 catalyzes the conversion of fatty acids to terminal alkenes
using hydrogen peroxide as a cofactor through a single step of decarboxylation. This
process has attracted broad interests for the sustainable production of fuels that are
compatible with the existing energy infrastructure.27–29 However, the practical application
of this enzyme is hampered by its sluggish turnover rate primarily due to the oxidative
damage of the heme prosthetic group by the excess H2O2 or the derivatized oxidative
species.30 We tried to circumvent this oxidative side reaction by a glucose oxidase (GOx)
enzyme based H2O2 in situ generating method, which has been described in Chapter 2. On
the other hand, the low solubility of substrate, i.e. fatty acids, in water is another important
factor limiting the synthetic application of this enzyme in conversional monophasic
reactions. In this chapter, we explored a surfactant-assisted emulsion process to study
OleTSA involved biphasic catalysis for fatty acid decarboxylation applications (Scheme
5.1).
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Surfactants are amphiphilic compounds that lower the interfacial tension between
organic and aqueous phases which have been widely used as emulsifiers, foaming agents,
and dispersants in industry and research.31 The decoration of surfactant on nanoparticles32
and proteins33,34 modulates their surface wetting properties and thus trigger interfacial
assembly to form emulsions. In this work, we screened a list of surfactants, and revealed
that the interaction between sodium dodecyl sulfate (SDS) and OleTSA can significantly
facilitate the emulsion droplet formation. We hypothesize that the SDS modified enzymes
acting as surface-active particles absorb on the oil/water interface via interfacial assembly,
a similar process to the formation of Pickering emulsion.
In the biphasic catalytic reactions, fatty acids were dissolved in the oil phase. Equal
amounts of SDS modify OleTSA and GOx enzyme were used to form emulsions, and Dmannose was added to initiate the tandem catalysis. We found that in the emulsion based
biphasic reactions, the production of terminal alkene is comparable to that in conventional
enzymatic reactions in aqueous solution, and above 96% of alkene product was enriched
in organic layer. Overall, this surfactant-assisted enzyme based emulsion system represents
an efficient method for biphasic catalysis and could be applied for enzyme based synthesis.
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Scheme 5.1 Schematic illustration of the of protein/surfactant complex formation, the selfassembly of protein/surfactant complex to generate emulsions.
5.2. EXPERIMENTAL DETAILS
5.2.1. MATERIALS
Eicosanoic acid (C20:0), stearic acid (C18:0), SDS and hexane were purchased
from BDH Chemicals. Cetrimonium bromide (CTAB), dodecyltrimethylammonium
bromide (DTAB), sodium Bis(2-ethylhexyl) sulfosuccinate (AOT), Trion X -100 and 1hexadecene was purchased from TCI chemicals. GOx from Aspergillus niger and H2O2
were purchased from Sigma. D-Glucose was purchased from Fisher. All chemicals and
solvents used were of analytical grade and were used as received from commercial sources.
200 mM K2HPO4, 100 mM NaCl, pH 7.4 was used as buffer A unless otherwise noted.
5.2.2. PROTEIN EXPRESSION AND PURIFICATION
The protein expression and purification process is the same as described in Chapter
2. Briefly, the kanamycin-resistant plasmid T5 containing a OleTSA-His6 gene was
transformed BL21(DE3) containing the chloramphenicol-resistant pTF2 plasmid encoding
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for GroEL/GroES/Tig chaperones. A modified Terrific Broth (TB) (24 g/L yeast extract,
12 g/L tryptone, 4 g/L peptone) supplemented with 50 μg/mL kanamycin and 20 μg/mL
chloramphenicol was used for culturing. 125 mg/L thiamine, and trace metals, 100 μM
IPTG, 10 ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid were added for protein
expression, which was done at 18 °C for 16-18 h.26 The protein was purified using nickelnitriloacetic acid (Ni-NTA) affinity chromatography followed by Butyl-S-Sepharose
column polishing step. Fractions with an Rz value (Abs418 nm/Abs280 nm) above 1.2
were pooled and dialyzed against 200 mM KPi pH 8. Proteins were stored at -80 °C until
further use.26
5.2.3. EMULSIONS GENERATION VIA INTERFACIAL ASSEMBLY
The surfactants were dissolved in H2O (unless otherwise noted), then mixed with
protein(s) solution, and incubated at room temperature for 10 min. Generally, the final
concentration of surfactants used is lower than their critical micelle concentration (CMC,
unless otherwise noted, see Table 5.1). Then equal volume of hexane was added into the
above solution in a 1.5 mL tube. Shake the mixture by hand for several minutes to generate
emulsions. For example, for SDS assisted enzyme emulsion formation, 150 μL of 6 mM
SDS in H2O was mixed with 150 μL of 10 μM OleTSA in buffer A in a 1.5 mL tube and
incubated for 10 minutes at room temperature before 300 μL hexane was added. The
mixture was shaken gently for 1-3 minutes for emulsion formation. The emulsions were
not purified for further characterization.
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5.2.4 CHARACTERIZATION OF THE PROTEIN-SDS INTERACTION AND
EMULSIONS
Fluorescent spectrum of OleT enzyme solution in the presence and absence of
surfactant was measured by Varian Eclipse fluorescence spectrophotometer. The zeta
potential was measured with dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern
Instruments). UV-Visible spectroscopy on an HP 8453 spectrophotometer and a quartz
cuvette with 1 cm path length were used for UV-Vis test. For confocal imaging, EGFP/SDS
solution was used as aqueous phase, hexane was used as organic phase for emulsion
generation, excited at 488 nm. An organic soluble dye Nile red was used to stain the oil
phase of OleTSA/SDS emulsions.
5.2.5 ENZYMATIC REACTION IN BIPHASIC CATALYSIS AND THE ACTIVITY
TEST
Aqueous solution (300 μL) including 5 μM OleTSA, 5 μM GOx and 0.3 mM SDS
in buffer A was incubated at room temperature for 10 minutes in a 1.5 mL Eppendorf tube.
Hexane (300 μL) with 4 mM eicosanoic acid was used as the organic solution, which was
added into the above aqueous solution in the tube and shaken for several minutes. DMannose was added to initiate the reaction (the final concentration was controlled at 7
mM). After 60 minutes’ reaction, the emulsion phase and aqueous phase were separated
into two 1.5 mL tubes. 10% HCL was added to quench the reactions. Then internal standard
was added. For emulsion phase, centrifuge at 14000 g for 2 minutes to breakdown the oil
drops and run the sample on GC. For aqueous phase, use the same volume of chloroform
for extraction, run the chloroform layer on GC.
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5.3. RESULT AND DISCUSSION
5.3.1. SURFACTANT SELECTION
Surfactants with opposite charge to proteins have been reported to interact with
proteins through electrostatic interactions for interfacial assembly study.34 In this work, we
expanded the selection range and included different types of surfactants in order to identify
the suitable one interacting with the OleTSA to form emulsion efficiently while sustaining
enzyme activity (Table 5.1). We found that both negative and positive charged surfactants
could facilitate the OleTSA based emulsion formation, though the emulsion droplet size and
stability could be varied depending on the charge, size and other properties of individual
surfactant. Among them, SDS was chosen because the interaction between SDS and
OleTSA significantly facilitated the emulsions’ formation and stabilization.
5.3.2. OLETSA SDS INTERACTION CHARACTERIZATION
The interaction between SDS and denatured proteins has been well established. For
example, high concentration of SDS (e.g. 80 mM ) was used to coat denatured proteins and
mask its intrinsic charge for SDS-PAGE analysis.35 We tested different concentration of
SDS (Table 5.1) and figured out that 60:1 (e.g. 0.3 mM SDS and 5 μM OleT) was the
optimal ratio to facilate the emulsion formation while with the enzyme activity susained.
As shown in Figure 5.2A, the florscence spectrum of OleTSA did not change after SDS
treating suggesting sustained enzyme conformation. An obvious heme spectrum shift was
abserved with SDS treatment indicating that some SDS molecules entered into the enzyme
active center interferring the spin state of heme (Figure 5.2B). However, this effect did not
influence enzyme activity significantly (Figure 5.2C). Formation of the OleTSA/SDS
complex was confirmed by the change of zeta potential from -7.5 to -10.3 after a SDS
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treatment. Moreover, higher concentration of slat may interupt the enzyme/SDS interaction
and interfer the complex formation (Figure 5.2D). This is consistent with our hypothesis
that the negative charged SDS can interact with the positive residues on OleT surface, thus
decreased its zeta potential.
5.3.2. INTERFACIAL ASSEMBLY OF OLETSA-SDS TO FORM EMULSIONS AND
ITS CHARACTERIZATION
Hexane as oil phase and OleTSA/SDS dissolved in aqueous phase were used to
generate microemulsions via interfacial assembly. As describe above, equal volume of
hexane was added into Ole/SDS solution, with gentle shaking by hand, emulsions could be
obtained. As controls, OleT enzyme only solution or SDS only solution, there was not
obvious and stable emulsions formed (Figure 5.3A). These results further confirmed that
the modification of OleT by SDS is key for a successful emulsion formation (likely due to
the partial hydrophobilized effect). As shown in Figure 5.3B, the droplet size range of
modified OleT/hexane emulsions was from ~50 – 300 μm. To visualize the type of
emulsions, we applied water-immiscible Nile Red to stain the organic phase, in which red
fluorescence only appeared in droplets indicating that oil-in-water (O/W) emulsions were
formed (Figure 5.3C). In addition, we used EGFP protein solution to carry out a similar
emulsion process in hexane. As expected, green emission was only observed in the
continuous phase (Figure 5.3D). Based on above results, an oil-in-water (O/W) emulsion
forming process via interfacial assembly was proposed and shown in Scheme 5.1.

132

Table 5.1 Surfactants used to test emulsion formation
CMC
(mM)*

Tested
Conc.
(mM)

Emulsion
Formation
(Y/N)

SDS

8.2

0.01 – 3

Y

CTAB

1.0

2.0

Y

DTAB

14.5

3.0

Y

AOT

2.1

1.0 and 7.0

N

Trion X 100

2.4

2.0

NA

Sodium
Cholate

14.0

10.0

Y

Surfactant
name

Structure

Note: OleTSA (5 μM) as aqueous solution and hexane as organic phase were used for all
tests. *CMC value is based on reported data at 25 °C in water.36,37 NA: Surfactant itself
can form emulsion with hexane. So the effect of the surfactant cannot determined
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Figure 5.2 (A) Fluorescence spectrum of OleTSA enzyme and SDS treated OleTSA enzyme
excited at 280 nm. (B) UV-Vis spectrum of OleTSA and SDS treated OleTSA. (C) Activity
comparison of OleT and SDS treated OleTSA. SDS treated OleTSA or free OleTSA (5 μM),
eicosanoic acid (1 mM), GOx (5 μM), mannose (7 mM) were incubated at room
temperature for 60 minutes. (D) Zeta potential test of OleT solution and SDS treated OleT
solution with two different buffers. For ‘low salt’ sample: 100 mM K2HPO4, 50 mM NaCl,
pH 7.4 was used for SDS/OleTSA incubation. For ‘high salt’ sample: 100 mM K2HPO4, 50
mM NaCl, pH 7.4 was used for SDS/OleTSA incubation. For all SDS treated samples, SDS
(0.3 mM) and OleT (5 μM) was incubated at room temperature for 10 minutes.
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Figure 5.3 (A) Photographs of hexane/water Pickering emulsions. Shaking of SDS
solution and hexane (1) or protein solution and hexane (3) do not form emulsions, while
shaking of SDS/protein solution and hexane form emulsions easily. (B) Fluorescence
microscopy images of EGFP/SDS stabilized Pickering emulsion with emission of 488 nm.
(C) optical microscopy of OleTSA/SDS. (D) Fluorescence microscopy images of
OleTSA/SDS stabilized Pickering emulsion with oil-soluble Nile red. Scale bars: 100 μm.
5.3.3. BIPHASIC CATALYSIS USING OLET-SDS/HEXANE OIL-IN-WATER
EMULSIONS
OleT enzyme-based catalysis is hampered by the poor solubility of substrates (i.e.
fatty acids) and products (i.e. terminal alkene). Furthermore, the inefficient product
purification step (for example extraction) is also a major obstacle for its real synthetic
application. Fortunately, both the fatty acids and terminal alkene products have high
solubility in hexane and other organic solvents. Herein, we propose to use the emulsion
based biphasic approach to optimize the OleT catalysis. In Chapter 2, we described a H2O2
in situ generation method to improve OleT catalysis with coupling to GOx enzyme. Based
on a similar process showing in Scheme 1, a multienzyme based oil-in-water emulsion
process was carried out.
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In this study, 4 mM eicosanoic acid (C20 FA) was dissolved in hexane as organic
phase. An OleT-SDS and GOx-SDS enzyme mixture was used as aqueous phase. With
following a gentle shaking by hand, the GOx-SDS/OleT-SDS droplets were formed
(Figure 5.4A). D-mannose (7 mM) as GOx substrate was added to initiate the tandem
catalysis. Nonadecene product was calculated in both oil and aqueous phase after the
reaction. As shown in Figure 5.4B and 5.4C, we found that the produced alkene in the
biphasic reaction was comparable to that in conventional one-phase enzymatic reactions,
while above 96% of the product was enriched in organic phase showing unparalleled
advantages. It is noteworthy that though the alkene production obtained in the biphasic
reaction was similar to that in conventional enzymatic reaction, the enzyme at the water/oil
interface displayed higher activity than that in control samples, because only the portion of
enzymes absorbed at the interface contributed the fatty acids conversion, and the free
enzymes could not catalyze the conversion due to the separation of substrate in oil phase
and the free enzymes in aqueous phase.
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Figure 5.4 (A) Scheme of OleTSA-SDS/GOX-SDS stabilized oil drops and the biphasic
catalysis (top) and optical microscopy of OleTSA-SDS/GOX-SDS hexane droplet (bottom).
Scale bar: 100 μm. (B) GC spectrum of nonadecene product distributed in organic and
aqueous phase of the biphasic reaction. A conversional one-phase reaction was used as
control. (C) Nonadecene product distribution calculation in the biphasic reactions and the
control reaction. Reaction condition: for biphasic reaction, 5 μM of SDS treated OleT and
5 μM SDS treated GOx, 4 mM eicosanoic acid dissolved in hexane, 7 mM mannose,
incubation at room temperature for 60 minutes. For control reaction, the same condition as
in the biphasic reaction above was used without hexane.
5.4 CONCLUSION
In summary, we have demonstrated a surfactant assisted enzyme based interfacial
assembly system, in which the modified enzymes serving as ‘surface active’ particles were
utilized to form oil-in-water emulsions. With this model, an efficient biphasic catalysis was
carried out. The excellent catalytic efficiency of the emulsions was primarily attributed to
the improved interfacial area compared to conventional biphasic reactions. More
importantly, more than 96% of terminal alkene product was enriched in the organic phase
during the catalysis showing unparalleled advance compared to the conventional enzymatic
reactions.
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CHAPTER 6
FUTURE PERSPECTIVES
In this dissertation, we demonstrate that protein(s) co-assembly can be a viable
approach to manipulate and improve the multistep and multienzyme based catalysis via
different mechanisms. More study to further understand the co-assembly process and its
effects on enzyme catalysis will be beneficial to expand such strategy in enzyme
engineering. In this chapter, we provide some perspectives on future works.
In Chapter 1, we report that the products with different oxidation state can be
enriched depending on the side groups of the substrates in CmlI catalyzed reactions, which
makes this enzyme and polymer-enzyme NPs very useful in synthetic applications. Further
investigations on a broad range of substrates of CmlI will be worth to try. In addition, colocalization of CmlI with some non-natural protein redox partners via the polymer protein
co-assembly will be an interesting direction to expand the polymer-multienzyme
assembly’s applications in CmlI catalysis.
For Chapter 2, the varied kinetics of GOx with different sugars provide useful tools
to control H2O2 releasing process, which can be used to leverage the downstream OleTSA
or other peroxygenases/peroxidase catalysis. OleTSA displays a relative broad H2O2responsive window and varied kinetics on different acids making it a unique model for
GOx coupled tandem catalysis study. More detailed kinetics studies of both enzymes will
provide useful information to understand the process and further optimize the enzyme
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cascade catalysis. This information can also be used for simulation study to illustrate the
proposed ‘channel-like’ effect on the polymer-multienzyme complexes.
Also in this part of work, we clearly demonstrate that, with GOx coupling, heme
bleaching of OleTSA can be mostly avoided during the catalysis. It will be promising to
explore different recycling systems to maximize the reusability of these enzymes.
Immobilization enzymes on inorganic nanoparticles or flow reactors can be used for such
applications. In these processes, the substrate/O2 consumption, product inhibition and pH
changing problems limiting the enzyme activity can be addressed. Importantly, the
polymer-GOx/OleTSA NPs generated by co-assembly can be readily adapted in the flow
reaction systems, providing excellent platform for biofuel production applications.
Notably glucose is much cheaper than mannose and more accessible (e.g. from
different bio-processes) in the practical synthesis, so it is worth to optimize the reaction
conditions with glucose as the substrate (for example, by adjusting the ratio of GOx and
OleT to co-assembly with different polymers).
In Chapter 3, the pyridine-containing polymer protein co-assembly used here
represents

a

unique

multistep/multicomponent-involved

assembly

system.

We

demonstrated that the fast mixing imparted effects on the co-assembly process and
increased the homogeneity of the resultant NPs, which is consistent with our hypothesis
that the adsorption of proteins on polymer colloids (i.e. aggregation step) is the ratelimiting step. More detailed descriptions about the process (e.g. aggregation timescale) are
needed to further understand the co-assembly process. With this EK-based microfluidic
system, the mixing process can be adjusted by electric field and flow rates. High-resolution
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imaging system can be easily integrated. So it provides an excellent platform to further
study and improve the polymer-protein(s) co-assembly process.
In Chapter 4, we reported a novel phenomenon that small molecules could
strikingly enhance OleTSA catalysis with changed kinetics. Structure data will be helpful to
understand the origins of the enhancement. In addition, we found that the small molecules
showed very different effects on different substrates including fatty acids and non-natural
substrates. We observed less enhanced effect in the reactions with high turnover rate further
supporting the H2O2 oxidative stress related mechanism. We speculate that some nonnatural substrates (e.g. 3-(4-methoxyyphennyl) propionic acid) themselves can serve as
OleT activators based on their unparalleled turnover rates and the structure similarity to the
small molecules we reported. Further study to illustrate these observations will be helpful
to understand the enhanced effects.
In Chapter 5, the preliminary data showed a promising GOx/OleT based biphasic
catalytic system. Some important parameters and processes need to be characterized for
further optimization in the future include:
(1) The loading efficiency of OleT and GOx on the microemulsions. The different
surface charge distribution of the two enzymes makes the interactions between enzymes
and surfactants varied, which will cause different enzyme loading efficiency of the
microemulsions.
(2) The activity of OleT on the interface of microemulsions. As analyzed in Chapter
5, we speculate that OleT enzyme activity can be greatly increased after the interfacial
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assembly than that in aqueous solution. More direct evidence is needed to identify this
possibility.
(3) The activity of GOx on the microemulsions. We assume that GOx enzyme
activity is not affected in the working concentration of surfactants used in this work, which
need to be confirmed.
(4) The interfacial assembly process. Different surfactants showed different effects
on the microemulsions’ formation, stability and enzymatic activity suggesting complex
interfacial assembly behaviors in the system. More in-depth investigations are needed to
understand the assembly process.
(5) Other microstructures formed in the multiphase system. While emulsions were
observed in the enzyme/surfactants/hexane system, more study is needed to identify if any
other micro- or nanostructures (e.g. micelles) were generated and contributed to the
enzymatic activity.
(6) Surfactant structures. Based on the further study, some rational designed
surfactants can be developed to generate microemulsions with having desired property (e.g.
reversibility, recyclability).
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